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 CD4 T cells play important roles in adaptive immune responses. Conventional 
understanding of CD4 T cell development is that the MHC class II molecules on cortical 
thymic epithelial cell are necessary for selection, as shown in mouse models. However, 
increasing evidence suggests that CD4 T cell selection mediated by hematopoietic cells 
such as thymocytes also occurs in humans as well as in mouse models. Thymocyte-
selected CD4 T cells (T-CD4 T cells) are shown to be different from epithelial cell-
selected CD4 T cells (E-CD4) in many aspects including developmental requirements 
and functional characteristics.  
 In this study, the strength of TCR signaling necessary for T-CD4 T cell 
development and the role of T-CD4 T cells during bacteria infection was investigated. In 
contrast to E-CD4 T cells, T-CD4 T cells were selected more efficiently when TCR 
signaling was weakened. In addition, T-CD4 T cell development relied on the presence of 
the promyelocytic leukemia zinc finger protein, a transcription factor essential for 
invariant NKT cell generation. The distinct developmental process mediated by 
thymocytes resulted in T-CD4 T cells possessing a suppressive function. Instead of 
promoting host immunity as E-CD4 T cells do, T-CD4 T cells suppressed anti-Listerial 
responses, evidenced by the reduced frequency and cytotoxicity of Listeria-specific CD8 
T cells during both the primary and the memory immune response. Studies in this 
dissertation revealed the novel suppressive function of T-CD4 T cells, which is most 
likely caused by the differential signaling delivered during thymocyte-thymocyte 







1.1 Mammalian immune system 
1.1.1    Innate immunity  
Living organisms are continuously exposed to a great complexity of 
nonpathogenic and pathogenic microorganisms. Mammalians have evolved an immune 
system composed of innate and adaptive compartments as a defense against these 
invaders (1, 2). The innate immune system is mobilized within hours after infection and 
is responsible for destroying the vast majority of microorganisms (3). A couple of days 
later, the adaptive immunity system is recruited to fight against prolonged infection and 
establishes enhanced protection in case of repeated exposures to the same pathogen.  
 
Both the inflammatory environment and cell recruitment in innate immunity are 
initiated by cytokines and other molecules produced by infected and activated cells (4-7). 
Inflammation causes locally increased vascular diameter and permeability, facilitating 
cell attachment and extravasation (8, 9). Professional phagocytes, including neutrophils, 
macrophages and monocytes that can differentiate into macrophages, are important for 
the clearance of intracellular pathogens (10, 11). The engulfed pathogens are destroyed 
intracellularly by a number of oxygen-containing compounds generated through oxygen-
dependent pathways (12, 13) or by pre-formed substances released from granules and 
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lysosomes once infused with phagosomes (14, 15). Another important innate cell 
population, the nature killer (NK) cells, constantly survey the periphery and receive 
regulatory signals through activating and inhibitory receptors to control their activity 
(16). They are activated when the infected cells down-regulate NK cell inhibitory 
receptors such as MHC class I and Ly49, which results in the derepression of NK cell 
activating signals through receptors such as NKG2D. NK cell activation leads to the 
production of large amounts of IFN-! as well as perforin/granzyme-mediated cytolysis 
(17). Extracellular pathogens can be destroyed by mast cells and polymorphonuclear 
leukocytes (PMNs) such as neutrophils, eosinophils and basophils (18, 19). These cells 
can be activated by physical destruction or IgE ligation, and by the process of 
degranulation, release preformed inflammatory mediators stored in secretory granules 
(20). The secreted mediators include biogenic amines such as histamine and 
proteoglycans, toxic oxygen-derived and nitrogen-derived products, as well as a spectrum 
of neutral proteases, lysozymes, and acid hydrolases. Most of these components function 
to destroy the microorganisms directly, and some are also toxic to host tissues. 
 
There are other humoral elements with crucial roles in the innate immune 
response system, foremost of which is the complement cascade (21). A major function of 
the complement cascade is to form a membrane-attack complex on target cells, which 
perforates cell membranes to cause cell death. In addition, complement cascade fragments 
C3a, C4a, and C5a cause mast cells to release inflammatory mediators such as histamine 
to increase vascular permeability, and C5a also acts as a powerful neutrophil 
chemoattractant (22). Cytokines play diverse roles in the process of pathogen clearance 
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as well. For example, type I interferons stimulate the synthesis of antiviral proteins to 
limit viral replication (23-25), the nuclear myxovirus-resistance proteins sequester viral 
ribonucleoproteins in specific subcellular compartments, the 2',5'-oligoadenylate 
synthetase as well as RNase L breaks down RNAs, and the RNA-dependent protein 
kinases inhibit translational processes (26). IL-1 and IL-6 induce the production of acute 
phase proteins from the liver (27) to enhance the resistance to infection and to promote 
the repair of damaged tissue (28, 29). TNF-# and IFN-! synergistically enhance the 
antimicrobial action of the macrophages, particularly by inducing the production of nitric 
oxide and superoxide ions (30).  
 
Although innate immunity is prompt and essential for the initial control of 
infection, it is pathogen-nonspecific. It identifies and distinguishes self from foreign 
pathogens by recognizing pathogen-associated molecular patterns (PAMPs) that are 
shared by groups of related microbes but are rarely associated with pathogen infected 
host cells (31, 32). In addition, innate immunity does not improve with repeated exposure 
to a given infection, and therefore lacks the potential for immunogenic memory. 
  
1.1.2    Adaptive immunity  
As the innate immune response goes on, adaptive immunity is developed in 
secondary lymphoid organs. Cells from the infected site carry pathogens to draining 
lymph nodes through the high endothelial venules (HEV) and afferent lymphatic vessels 
(33, 34), and to the spleen through the blood vessels in the red pulp. 
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T cells are activated in T cell zones by recognizing pathogen-derived peptides 
presented by MHC Class I or II complexes on antigen presenting cells (APC) (35, 36). T 
cell receptors (TCRs) are clonally specific (37, 38) in that they differ from one another in 
gene sequences and tertiary structures to distinguish slightly different epitopes. As a 
result, despite the presence of millions of T cells, only a few recognize and respond to a 
specific pathogen. With the assistance of co-stimulatory factors, T cells recognizing 
antigen undergo dramatic clonal expansion and acquire effector functions in a couple of 
days. Activated CD8 T cells up-regulate chemokine receptors such as CCR5 causing 
them to migrate to the infected site (39), where they produce large amounts of IFN-! to 
promote cellular immunity as well as directly kill infected cells by inducing Fas-mediated 
apoptosis and perforin/granzyme-mediated cytolysis (40). Additionally, antigen activated 
CD4 T cells down-regulate CCR7 and migrate toward the edge of the T cell zone to 
interact with B cells that are migrating from the opposite direction (40). Meanwhile, CD4 
T cells further differentiate into T helper cells with different migration potentials: T 
helper 1 (Th1) cells produce IFN-! and up-regulate CCR5 and CXCR3 to migrate in 
response to chemokines such as IP-10, MIP-1# and MIP-$ that are induced by pro-
inflammatory cytokines (41-43). T helper 2 (Th2) cells produce IL-4, IL-5 and IL-13 
cytokines, preferentially express CCR3 and CCR4 and migrate in response to chemokine 
gradients of eotaxin and MCPs induced by type 2 cytokines (44, 45). IL-17-producing 
CD4 T cells express CCR6 and therefore preferentially migrate to tissues that express its 
ligand CCL20 (46). Follicular helper cells (ThFH), produce IL-21, up-regulate CXCR5 
and migrate to the B cell zone in lymphoid tissues to help with B cell functional 
differentiation (47, 48).  
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B cells reside in the B cell zone at steady state. Like TCRs, B cell receptors 
(BCRs) are generated with clonal specificity by gene rearrangement during B cell 
development. But unlike T cells that require antigens to be presented by MHC molecules 
for recognition to occur, B cells recognize and engulf free antigens. Antigen binding to 
BCRs induces the down-regulation of CXCR5 and the up-regulation of CCR7 to instruct 
B cells to migrate to the edge of the B cell follicles (49), where they receive help from the 
T cells migrating from the T cell zone. The interaction of B and T cells is antigen-
sepcific, in that B cells process the antigen recognized by the BCR and present the 
resulting peptides to T cells in concert with MHC class II molecules. The interaction with 
activated CD4 T cells results in B cell activation through the CD40-CD40L signaling 
pathway (50). Then with several rounds of proliferation, B cells differentiate into 
antibody-secreting plasma cells and undergo antibody class switching that is regulated by 
various cytokines. In the mouse, IFN-! preferentially induces class switching to IgG3 and 
IgG2a, IL-4 to IgG1 and IgE, and IL-5 to IgA (50, 51). 
 
To fight against invasion effectively, the host must mount an appropriate immune 
response, which depends on the nature of the infection (52, 53): cellular immunity mainly 
deals with intracellular pathogens including various bacteria and viruses; antibody-
mediated humoral immunity is effective to cope with extracellular pathogens such as 
parasites. The immune response to antigens varies depending upon the differentiation 
direction taken by CD4 T cells. Strong TCR stimulation with pro-inflammatory cytokines 
such as IL-12 promote the differentiation of Th1 cells to produce IFN-!, a cytokine 
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critical for the promotion of CD8 T cell function and the full activation of macrophages 
(54) against intracellular pathogens (55). Low antigen levels and early IL-4 production by 
innate immune cells drive Th2 differentiation. Th2 cytokines facilitate B cells to produce 
antibodies and promote the killing of bacteria and parasites by eosinophils, basophils and 
mast cells. More recently, IL-17-producing CD4 T cells have been identified that are 
distinct from Th1 and Th2 cells and have been named Th17 cells. Their differentiation 
requires regulatory cytokine TGF-$ and pro-inflammatory IL-6 (56, 57). The roles of 
Th17 cells have been largely associated with various inflammatory autoimmune diseases 
(58), although it is also suggested that the massive inflammation induced by Th17 cells is 
necessary for the clearance of specific types of pathogens that are not adequately dealt 
with by Th1 or Th2 immunity (59). It should be noted that both cellular and humoral 
immunities are involved in most immune responses although on a case by case basis, one 
type of response is often dominant and more responsible for pathogen clearance than the 
other.  
 
1.1.3    Immune memory  
When the immune response to pathogen is appropriate and successful, the 
immune response abates after pathogen clearance. Most of the active antigen-specific 
immune cells are susceptible to apoptosis and rapidly die with the absence of antigenic 
stimuli and survival cytokines (60). This contraction process is very important for T and 
B cell homeostasis. Some of these cells, however, survive this phase and persist in the 
periphery as memory immune cells, which are responsible for a faster and more potent 
recall response upon a second and later encounter with the same pathogen (61-65). 
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Humoral memory is provided by long-lived plasma cells and is marked by a persistent 
antigen-specific antibody level in the periphery (66-68). Long-lived memory B cells 
reside in specific niches in the bone marrow or secondary lymphoid organs, where they 
are maintained by TNF, IL-5 and IL-6 cytokines, as well as by certain co-stimulatory 
molecules such as the CD44 ligand hyaluronic acid (69-71). Memory T cells reside in the 
periphery and are maintained by IL-7 and IL-15 (72-75) as well as through MHC-
dependent homeostatic proliferation (76).  
 
Memory T cells can be categorized into two major types: the central memory T 
cells (TCM) and effector memory T cells (TTM). These two memory cell types differ in 
their location as well as function (77). TCM express high levels of CD62L and CCR7, the 
two receptors required for the extravasation of cells through HEV and for their migration 
to T cell areas of secondary lymphoid organs (78, 79). Although naïve T cells also 
express CD62L and CCR7, TCM are equipped with higher sensitivity to TCR stimulation 
and their activation is less dependent on co-stimulation. The activated TCM quickly 
become effector cells, down-regulating CCR7 and CD62L and then migrating to the 
infected site where they produce large amounts of effector cytokines (80). TEM, in 
comparison, display low levels of CCR7 and CD62L but express chemokine receptors 
and adhesion molecules that are responsible for the homing to inflamed tissues. 
Therefore, TEM either circulate in the periphery or populate the site of former infection, 
and are ready to exert rapid effector function within hours upon re-infection (80).  
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The quality of T cell memory is determined by multiple factors during primary 
responses. First, TCR signaling quality is critical for T cell expansion and survival, which 
in turn affects the frequency of memory precursors (81-84). In addition, co-stimulatory 
signals through B7 and TNF family receptors also contribute to increasing the size of the 
memory T cell populations (85-89). Second, inflammatory cytokines such as IL-12 and 
IFN-! play key roles in determining whether the generated effector T cells are with or 
without T cell memory potential (72, 90-92). For a given dose of antigen, a low 
inflammatory environment promotes memory T cell development, while increased 
inflammatory signals decrease the ratio of memory precursors to terminally differentiated 
effector T cells (93, 94). Third, studies with various mouse models have shown the 
indispensable role of CD4 T cells for the immune memory of cytotoxic T lymphocytes 
(CTLs) (55, 95-97). During the primary response, T helper cells assist in dendritic cell 
(DC) maturation through the CD40L-CD40 signaling pathway (98) and enhance the 
chemotactic response of naïve CD8 T cells to mature DCs (99). It has also been reported 
that CD4 T cells are needed for the long-term maintenance of memory CTLs (100). In 
addition, the early production of IL-2 by memory CD4 T cells upon re-infection 
facilitates the effective expansion and robust recall capacity of the memory CTLs (92).  
1.2 !" T cell development 
1.2.1    The generation of !" T cells in the thymus  
T cells are generated from bone marrow (BM)-derived lymphoid progenitors. 
They enter the thymus at the corticomedullary junction and migrate outward to the cortex 
while undergoing a series of genetic programming. The early development of CD4/CD8 
double negative (DN) cells can be tracked by the expression of CD25 and CD44 and thus 
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divided into four stages: DN1 (CD25loCD44hi), DN2 (CD25hiCD44hi), DN3 
(CD25hiCD44lo) and DN4 (CD25loCD44lo) (101). At the DN3 stage, thymocytes undergo 
TCR! chain rearrangement. Each TCR gene contains multiple variable (V), diversity (D), 
and joining (J) region segments. The recombination of different V, D, and J segments 
with deletions and random insertions of nucleotides at the junction regions give rise to 
millions of different gene sequences (102). TCR$ rearrangement is allelic exclusive, and 
the first in-frame $ chain rearrangement stops further somatic recombination (103). The 
generated TCR$ chain pairs with a surrogate of the TCR# chain to assemble the pre-TCR 
complex to be expressed on the cell surface.  
 
The pre-TCR signaling leads to cell expansion and CD4/CD8 up-regulation (104). 
At the CD4/CD8 double positive (DP) stage, thymocytes rearrange the TCR" chain to 
express TCR#$ antigen receptors and to undergo positive selection (105). During positive 
selection, DP thymocytes are tested for their responsiveness to self-MHC molecules. 
Only those thymocytes that recognize the TCR ligands appropriately survive and 
continue with the developmental process (105). If the current #$ pair does not interact 
appropriately with the MHC complexes, the # chain rearrangement can be continued for 
new # chain products (106, 107). However, still about 90% of the DP thymocytes are 
eliminated at this stage because of inadequate TCR-MHC interaction (105).  
 
Coincident with the positive selection, two major T cell lineages are generated: 
CD4 T cells that recognize peptide-MHC class II complexes and CD8 T cells that 
recognize peptide-MHC class I complexes (108).  These positively selected single 
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positive (SP) thymocytes migrate to the medulla (109) for further maturation and  
undergo screening for self-reactivity, a process called negative selection (110, 111). 
Medullary thymic epithelial cells express and process various tissue-specific antigens to 
present them to thymocytes through MHC complexes (112). TCRs that recognize these 
self peptide-MHC complexes with high affinity elicit strong TCR signals that lead to cell 
apoptosis. By negative selection, most of the self-reactive thymocytes are eliminated 
from the immune system and self-tolerance in the periphery is established. Thus, positive 
and negative selection together generates a repertoire of T cells bearing TCRs with self-
MHC restriction and the ability to distinguish self from foreign antigens. 
 
1.2.2    TCR signaling during development  
 TCR signaling quality, which is a function of the strength of the TCR-MHC 
interaction, is the major determinant of the fate of thymocytes. On the cell surface, TCR 
is expressed as a complex of a TCR "! pair, a CD3 !% and a CD3 &% heterodimer as well 
as a CD3"" homodimer (113). The cytosolic tails of TCR chains are short and lack 
signaling domains. Instead, CD3 dimers contain the immunoreceptor tyrosine-based 
activation motifs (ITAMs) and function to initiate the intracellular signals after TCR 
activation (114, 115). As shown in Figure 1.1, the aggregation of TCR complexes results 
in transphosphorylation and activation of the Src family of protein tyrosine kinases 
(PTKs) Lck and Fyn that associate with the CD4 or CD8 co-receptor (116-119). The Src 
family PTKs phosphorylate ITAMs (120) to provide binding sites for other PTKs 
including ZAP70. Upon binding to the ITAMs, ZAP70 becomes activated (121, 122), and 
in turn phosphorylates the docking sites of adaptor proteins LAT and SLP-76 to recruit 
 11 
specific SH2 domain-containing proteins (122, 123). LAT serves as a docking scaffold 
for Grb2 family adapter proteins and kinases such as PI3K and PLC-#1 (124). SLP-76 
binds to the LAT complex through Gads and provides binding sites for proteins such as 
VAV, NCK, and ITK through its phosphorylated N-terminal tyrosine residues (125-128). 
SLP-76 association with Gads also contributes together to PLC-!1 phosphorylation (131). 
VAV and NCK are thought to integrate the activation of different pathways responsible 
for gene transcription and cytoskeletal rearrangement (129, 130), and ITK has been 
 
 
Figure 1.1 TCR signaling. Detailed description can be found in the text.  
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suggested to be important for the optimal activation of PLC-#1 (132).  
  
 Once activated, PLC-!1 cleaves phosphatidylinositol 4,5-bisphosphate into 
inositol-1,4,5-triphosphate (IP3) and diacylglycerol (DAG). IP3 binding to receptors on 
the endoplasmic reticulum initiates the release of intracellular calcium store. Increased 
intracellular calcium concentration activates phosphatase calcineurin, which 
dephosphorylates the cytoplasmic component of the NFAT transcription factors (133) 
and results in their translocation into the nucleus, where they form heterodimers with 
members of the AP-1 family to regulate gene transcription (134, 135). DAG responds to 
the increased intracellular calcium by activating PKC' and the downstream NF-(B 
pathways (136). DAG also activates the guanine nucleotide exchange factor (GEF) 
RasGRP1 and the downstream Ras-MEK-MAPK/ERK1/2 pathway (137). This signaling 
pathway is also regulated by another GEF, the son of sevenless (SOS) protein, which can 
be recruited by the adaptor protein Grb2. Ras-MEK-MAPK/ERK1/2 pathway leads to the 
activation of the transcription factors such as Egr-1 and Elk-1 (148). Various 
transcription factors form a network to regulate the expression and activity of the genes 
involved in thymocyte development.  
1.2.3    TCR signaling pathways responsible for positive and negative selection 
Several signaling pathways downstream of proximal TCR signaling are important 
for thymocyte positive selection (138, 139). One of these is the calcium–calcineurin–
NFAT signaling pathway (140). Mice with an inactivated regulatory subunit of 
calcineurin are clearly deficient in positive selection, as demonstrated by diminished 
TCR$hiCD69hi DP populations (141). NFAT4 deficient mice exhibit impaired positive 
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selection by increased apoptosis of DP thymocytes and reduced SP thymocyte number. 
Conversely, constitutive activation of calcineurin results in increased CD4 SP cell 
generation in a TCR transgenic mouse model (142).   
 
Ras-MEK-MAPK/ERK1/2 is another well-studied signaling pathway with a role 
in thymocyte positive selection. RasGRP1 deficient mice display profoundly impaired 
positive selection as seen by the very few SP thymocytes generated (143). Consistent 
with this observation, the disruption of this pathway with a dominant negative Ras (144-
146) or an inactivated ERK1 (147) selectively inhibits positive selection of thymocytes 
without altering negative selection. Egr-1seems to be the downstream target that is 
uniquely important for positive selection (148), and this is supported by the observation 
that enforced expression of Egr-1 partially rescued the positive selection of thymocytes in 
a HY TCR transgenic model (149).  
 
TCR signaling is very sensitive; a small increase in the affinity of TCR ligation 
can cause dramatic changes in the signaling kinetics of the downstream pathways. 
MAPKs have been suggested to account for the distinction between positive and negative 
selection on the basis of the TCR signaling intensity (150). At low stimulation levels, Ras 
is activated mainly by RasGRP1 at the Golgi aparati, which leads to the moderate activity 
of the Ras-ERK cascade and favors cell survival (151-153). Strong TCR ligation, 
however, results in enhanced phosphorylation of LAT and the recruitment of Grb2-SOS 
in addition to RasGRP1 from the cytosol to the plasma membrane (154). This results in 
strong and transient activation of the Ras-ERK cascade at the plasma membrane and the 
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activation of two other MAPKs, JNK and p38 (107, 155), which are not activated by 
RasGRP1 alone because of a higher activation threshold than that of ERK1/2 (156). 
These two MAPKs are thought to be specifically involved in negative selection, and 
further, the selective disruption of their activity impairs negative but not positive 
selection (156-158). Thymocyte apoptosis during negative selection seems to be Fas-
independent and instead is mediated by Bcl-2 family members and Nur77 (159). Bim 
deficient mice develop autoimmune disease due to undeleted auto-reactive thymocytes 
(160) and exhibit impaired superantigen-mediated negative selection (161). Similarly, the 
negative selection is impaired when the activity of Nur77 is inhibited (162).  
1.3 Thymocyte-selected CD4 (T-CD4) T cells 
1.3.1    The generation of T-CD4 T cells 
Conventionally, CD4 T cell generation is believed to be TEC-dependent. 
However, there has been increasing evidence suggesting that human CD4 T cells can be 
generated through an alternative pathway. For example, patients with bare lymphocyte 
syndrome (BLS) lack CD4 T cells due to defective MHC class II expression, and 
currently bone marrow transplantation (BMT) is the only curative treatment. The BMT 
treatment results in the restoration of functional CD4 T cells in many patients (163-166), 
indicating that in humans CD4 T cell generation is not absolutely dependent on TECs and 
can be mediated by bone marrow-derived cell types. Further studies support thymocytes 
as a mediator of CD4 T cell selection using the OP9-DL1 stromal cell line that supports T 
cell development (167). Mouse T cell precursors develop into CD8 but not CD4 T cells in 
the OP9-DL1 system because the stromal cells and mouse thymocytes express MHC 
class I but not class II. By contrast, human thymocytes that can express a substantial 
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amount of MHC class II molecules on their surface (168, 169) are generated when co-
cultured with OP9-DL1 cells (167). Physiologically speaking, it is hard to assess 
thymocyte-selected CD4 T cells in humans because there are not cell surface markers 
available to distinguish them from TEC-selected CD4 T cells, although a recent study 
reported that the transcription factor promyelocytic leukaemia zinc finger (PLZF) protein 
is expressed in thymocyte-selected but not TEC-selected human CD4 T cells (170).  
 
Considering the evidence of thymocyte-generated CD4 T cells in humans and the 
limited knowledge of this population, it became necessary to establish a similar CD4 T 
cell developmental system using mouse models. In 2005, we and others independently 
reported the generation of mouse CD4 T cells independent of the TEC-mediated pathway 
(171, 172). Both groups induced MHC class II expression on mouse thymocytes using a 
human CIITA transgene (CIITATg). CIITA is a master transactivator of MHC class II 
expression. It is conserved between humans and mice, and the transgenic expression of 
CIITA results in efficient MHC class II expression on mouse thymocytes (171, 172). The 
transfer of CIITATg BM to MHC class II-deficient hosts results in CD4 T cell restoration, 
which cannot be accomplished by wild type (WT) BM transfer to the same kind of host, 
confirming that thymocyte-mediated selection is independent of TEC-mediated selection 
in CD4 T cell generation. Thymocyte-selected CD4 T cells are named T-CD4 T cells, and 
conventional CD4 T cells selected by TEC are named E-CD4 T cells.  
 
In addition to selecting cell types, the developmental process of T- and E-CD4 T 
cells also differs in the requirement of co-stimulatory signals. One example is the type I 
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transmembrane proteins of the signaling lymphocyte activation molecule (SLAM) family. 
These are expressed restrictively in hematopoietic cells (173) and signal through the 
adaptor SLAM-associated protein (SAP) (174). Whereas SLAM pathways are 
dispensable for E-CD4 T cell generation, they are critical for T-CD4 T cell development. 
Leaving E-CD4 T cell generation intact, SLAM or Ly108 deficiency decreases and SAP 
deficiency almost abolishes T-CD4 T cell generation. (175). 
1.3.2    T-CD4 T cell functional characteristics  
E-CD4 T cells are conventional adaptive immune cells. Upon stimulation, they 
undergo several days of clonal expansion, during which the cells are programmed and 
differentiate into different T helper cells according to the type of the stimulation. 
Therefore, it takes several days for them to be ready for functional performance. By 
contrast, T-CD4 T cells exert effector function within hours after TCR stimulation both in 
vivo and in vitro (176). This functional property is reminiscent of cells of the innate 
immune response, and therefore is referred to as “innate-like”. Moreover, the Th1 and 
Th2 cytokine production of E-CD4 T cells is mutually exclusive, but certain T-CD4 T 
cells produce both Th1 and Th2 cytokines (176) under un-polarized conditions, and more 
remarkably, under Th1-skewing conditions as well (177).  Further studies have shown 
that T-CD4 T cells contain pre-formed mRNA of the Th2 cytokine IL-4 at steady state 
that is STAT6-independent (176).  
 
The physiological role of T-CD4 T cells has been investigated in several mouse 
models of immune diseases. First, T-CD4 T cells repress experimental autoimmune 
encephalomyelitis (EAE), indicated by lower disease scores and reduced IFN-! 
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production of MOG35–55-specific CD4 T cells in CIITATg mice compared to WT 
littermates (178). Second, T-CD4 T cells were protective in antigen-induced airway 
inflammation (176). Different from polyclonal stimulation by anti-CD3 antibody, T-CD4 
T cells did not enhance Th2 cytokine production in sensitized and aerosolically 
challenged CIITATg mice. Instead, these mice demonstrated decreased allergen-specific 
IgE levels in the serum, limited IL-13 and IL-17 transcripts in the lungs as well as reduced 
cell numbers in lung infiltrate compared to wild type mice. Third, in contrast to the 
reduced disease progression in the two models above, CIITATg mice exhibited aggravated 
disease development in a oxazolone-induced colitis model (179), although the 
mechanism of T-CD4 T cell functional disparities in these mouse models is not yet clear. 
In contrast to these adaptive immune responses, innate responses do not seem to be 
significantly affected by T-CD4 T cells, as CIITATg and wild type mice showed similar 
innate inflammation in dextran sodium sulfate-induced acute colitis (177).  
1.3.3    Other unconventional mouse T cell populations  
Besides T-CD4 T cells, several other T cell populations have been identified with 
unconventional developmental characteristics and immediate effector functionality. One 
of the most studied populations is the invariant natural killer T (iNKT) cells. They 
undergo TCR #$ rearrangement as conventional T cells and are either CD4+ or CD4/CD8 
double negative. As an innate-like T cell population, they produce IFN-! and IL-4 upon 
TCR stimulation and have been shown to regulate immune-related diseases such as 
asthma and cancer (182-184). They are called iNKT cells because they express certain 
NK cell markers including NK1.1, 2B4 (CD244) and CD94/NKG2 (180, 181), and 
because their TCR repertoire is much more limited than that of conventional T cells, and 
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preferentially express V#14-J#18/V$8.2 and V$7 in mice, and V#24-J#18/V$11 in 
humans (185, 186). Unlike conventional CD4 T cells, the TCRs of iNKT cells do not 
recognize peptide-MHC complexes expressed on TEC, but instead recognize glycolipids 
presented by the MHC class Ib molecule CD1d expressed on thymocytes (187). 
Moreover, iNKT cells express the transcription factor PLZF, which further distinguishes 
them from E-CD4 T cells (185, 186). Interestingly, not only do iNKT cells share the 
same selecting cell type with T-CD4 T cells, they also require the SLAM-SAP signaling 
pathways for their development (188).  
Unconventional CD8 T cells are another widely identified and investigated 
innate-like T cell population (189-195). Their antigen-independent cytokine secretion and 
NKG2D-dependent cytotoxicity are observed early after bacterial and viral infections 
(196-198). The generation of these innate-like CD8 T cells has heterogeneous causes. 
They can be selected by either TEC or hematopoietic cells, and they recognize MHC 
class Ib molecules such as H2-M3 and Qa-1 (199). H2-M3-restricted CD8 T cells 
recognize formyl-methionine-modified peptides typically found in bacterial and 
mitochondrial encoded proteins that are uncommonly found in the mammalian cytosol 
(200). Qa-1 molecules associate with peptides or lipids to positively select CD8## T cells 
that are also known as intestinal intraepithelial lymphocytes (201, 202). The TCR 
specificity of innate-like CD8 T cells does not seem to be as restrictive as that of 
conventional T cells. For example, a H2-M3-restricted TCR can recognize multiple 
unrelated peptides as long as they are N-terminal formylated (203). Moreover, the 
signaling requirement for innate-like CD8 T cell development is also different from that 
for conventional T cell development. First, reduced TCR signaling that compromises 
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conventional CD8 T cell development enriches innate-like CD8 T cell populations. 
Second, co-stimulatory pathways mediated by SLAM and CD28 that do not affect 
conventional CD8 T cell generation are critical for innate-like CD8 T cell generation and 
their functional properties (199).  
1.4 Listeria monocytogenes infection 
1.4.1    Infection course and the host innate immune response  
Listeria monocytogenes are gram-positive, rod-shaped facultative intracellular 
bacterium (204-206), which are ubiquitous in the environment and are recognized as an 
important food borne pathogen. Although it rarely causes serious symptoms in 
immunocompetent populations, L. monocytogenes causes septicaemia and meningitis in 
immunocompromised individuals as well as chorioamnionitis and septic abortion in 
pregnant women (207).  
 
L. monocytogenes infection and the immune responses triggered by the infection 
have been intensively characterized (207-213). The natural route of L. monocytogenes 
infection is through the gastrointestinal tract. The bacteria can traverse the epithelial cell 
layer into the bloodstream and spread systemically, which makes the spleen and liver the 
major infection sites. Macrophages and neutrophils are recruited within hours after 
infection, followed by monocytes that can differentiate into macrophages by TLR and/or 
cytokine stimulation (214, 215). These cells function to internalize and destroy the 
bacteria through reactive oxygen intermediate-dependent mechanisms (216, 217), which 
is critical for the initial control of the scale of the infection. The depletion of these cells 
remarkably enhances host susceptibility to L. monocytogenes infection (218-220). In 
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addition, NK cells and macrophages produce the cytokines IFN-! and TNFs that are 
important for L. monocytogenes clearance (221-223). IFN-! promotes macrophage 
activation (224) and MHC up-regulation (167, 225); TNFs recruit neutrophils and 
functionally synergize with IFN-!. Mice lacking these cytokines rapidly succumb to 
infection (212, 226, 227).  
1.4.2    Adaptive immunity to Listeria monocytogenes 
After being phagocytosed, L. monocytogenes can escape from the phagosome by 
secreting listeriolysin O (LLO) to permealize the phagosomal membrane. Once inside the 
cytosol, L. monocytogenes are processed through the MHC class I antigen-presenting 
pathway and thereby cause robust CD8 T cell responses (228, 229). Although adaptive 
immunity does not develop into full momentum until a couple of days into the infection, 
its programming starts early after infection: in the spleen and the draining lymph nodes, T 
cells are primed in the T cell zone by APCs such as CD11c-expressing DCs (230) within 
24 hours, and the later cell expansion is largely dependent on the antigen presentation 
within the first day (231). In addition, T cell survival at the contraction phase is inversely 
correlated with the pro-inflammatory environment early on (232, 233). In comparison, 
the innate immune responses after the first 24 hours have only a small effect on the 
kinetics and magnitude of CD8 T-cell response (233).  
 
L. monocytogenes-specific CD4 and CD8 T cells expand synchronically (234), 
with their frequencies in the spleen peaking approximately eight days after a primary 
infection and three days after a secondary infection. Studies using adoptive transfer 
models have shown that CD4 T cells promote the immune responses by IFN-! production 
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(212, 235). IFN-! in this case is likely to activate macrophages to become fully 
bactericidal, as in vitro studies have showed that treating macrophages with IFN-! 
prevents bacteria escaping from the phagosome (236). CD8 T cells mediate antigen-
specific lysis of infected cells through two major molecular pathways (237, 238). The 
granule exocytosis pathway requires the coordinated activity of perforin and granzymes 
released from the granules of activated CD8 T cells to activate the caspase cascade of the 
target cells to trigger apoptosis (239). Alternatively, activated CD8 T cells express Fas 
(CD95) ligand, which activates the Fas pathway in target cells to induce apoptosis (237, 
238). CD8 T cells with perforin deficiency display intact priming and expansion but 
compromised cytolytic activity and protective capacity against L. monocytogenes, 
especially in controlling cell-cell contact-dependent bacterial spread (240, 241). 
Remarkably, mice deficient in both perforin and Fas have dramatically reduced capacity 
for L. monocytogenes clearance compared with mice defective in only one of these, 
suggesting that the two killing pathways play complementary roles in host defense (242).  
 
L. monocytogenes infection is a useful model to study the dependency of CD4 T 
cell help in the establishment of CTL memory immunity. CD4 T cell deficient mice can 
recover from the primary infection efficiently, but they display defective bacterial 
clearance during a secondary L. monocytogenes infection (231, 243, 244) with 
dramatically compromised antigen-specific CTL proliferation (177). It seems that the 
CD4 T cell assistance is important during CD8 T cell priming, because their absence at 
this stage impairs CTL memory immunity but their depletion at a later stage does not 
affect the efficiency of CTL memory response (231, 243, 244). The role of CD4 T cells 
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has also been revealed in the homeostasis of memory CD8 T cells after the resolution of 
the infection. The number of Listeria-specific CTLs in CD4 T cell deficient hosts 
declines much faster over time than that in CD4 T cell sufficient hosts (100). The 
molecular mechanism of CD4 T cell function in the development of anti-Listerial CTL 
memory immunity remains elusive, except that pathways such as the CD40-CD40L co-
stimulatory pathway (245) have been shown to be dispensable for the process.  
1.5 Goals of the thesis 
The goals of this thesis are: first, to investigate the TCR signaling requirement for 
T-CD4 T cell development, and second, to study the function of T-CD4 T cells in a 
bacterial infection. 
 
To investigate TCR signaling requirement for T-CD4 T cell development, the 
effect of TCR signaling modulation on T-CD4 T cell development will be compared with 
that of E-CD4 T cells in different gene knockout models.  
 
To study the function of T-CD4 T cells in anti-bacterial immunity, antigen-





1. Alam, R. 1998. A brief review of the immune system. Prim Care 25:727-738. 
2. Carroll, M.C., and A.P. Prodeus. 1998. Linkages of innate and adaptive immunity. 
Curr Opin Immunol 10:36-40. 
3. Minton, K. 2010. Innate immunity: A chain reaction. Nat Rev Immunol 10:385. 
4. Aderem, A., and D.M. Underhill. 1999. Mechanisms of phagocytosis in 
macrophages. Annu Rev Immunol 17:593-623. 
5. Bratosin, D., J. Mazurier, J.P. Tissier, J. Estaquier, J.J. Huart, J.C. Ameisen, D. 
Aminoff, and J. Montreuil. 1998. Cellular and molecular mechanisms of 
senescent erythrocyte phagocytosis by macrophages. A review. Biochimie 80:173-
195. 
6. Griffin, F.M., Jr., and P.J. Mullinax. 1985. Augmentation of macrophage 
complement receptor function in vitro. V. Studies on the mechanisms of ligation 
of macrophage Fc receptors required to trigger macrophages to signal T 
lymphocytes to elaborate the lymphokine that activates macrophage C3 receptors 
for phagocytosis. J Immunol 135:344-349. 
7. Zipfel, P.F. 2009. Complement and immune defense: from innate immunity to 
human diseases. Immunol Lett 126:1-7. 
8. Silva, M.T. 2010. Neutrophils and macrophages work in concert as inducers and 
effectors of adaptive immunity against extracellular and intracellular microbial 
pathogens. J Leukoc Biol 87:805-813. 
9. Spector, W.G. 1970. The macrophage in inflammation. Ser Haematol 3:132-144. 
10. Poon, I.K., M.D. Hulett, and C.R. Parish. 2010. Molecular mechanisms of late 
apoptotic/necrotic cell clearance. Cell Death Differ 17:381-397. 
11. Diacovich, L., and J.P. Gorvel. 2010. Bacterial manipulation of innate immunity 
to promote infection. Nat Rev Microbiol 8:117-128. 
12. Robinson, J.M. 2009. Phagocytic leukocytes and reactive oxygen species. 
Histochem Cell Biol 131:465-469. 
13. Robinson, J.M. 2008. Reactive oxygen species in phagocytic leukocytes. 
Histochem Cell Biol 130:281-297. 
14. Catterall, J.R., S.D. Sharma, and J.S. Remington. 1986. Oxygen-independent 
killing by alveolar macrophages. J Exp Med 163:1113-1131. 
15. Sasahara, T., N. Ikewaki, H. Tamauchi, and N. Osawa. 1992. Oxygen-
independent antimicrobial activity against Salmonella enteritidis of specially 
activated macrophage with living vaccine. Kitasato Arch Exp Med 65:225-237. 
16. Andoniou, C.E., J.D. Coudert, and M.A. Degli-Esposti. 2008. Killers and beyond: 
NK-cell-mediated control of immune responses. Eur J Immunol 38:2938-2942. 
17. Hallett, W.H., and W.J. Murphy. 2006. Positive and negative regulation of 
Natural Killer cells: therapeutic implications. Semin Cancer Biol 16:367-382. 
18. Abraham, S.N., and M. Arock. 1998. Mast cells and basophils in innate immunity. 
Semin Immunol 10:373-381. 
 24 
19. Katsanos, G.S., A. Anogeianaki, C. Orso, S. Tete, V. Salini, P.L. Antinolfi, and 
G. Sabatino. 2008. Mast cells and chemokines. J Biol Regul Homeost Agents 
22:145-151. 
20. Soehnlein, O., C. Weber, and L. Lindbom. 2009. Neutrophil granule proteins tune 
monocytic cell function. Trends Immunol 30:538-546. 
21. Tomlinson, S. 1993. Complement defense mechanisms. Curr Opin Immunol 5:83-
89. 
22. Dunkelberger, J.R., and W.C. Song. 2010. Complement and its role in innate and 
adaptive immune responses. Cell Res 20:34-50. 
23. Chang, K.O., and D.W. George. 2007. Interferons and ribavirin effectively inhibit 
Norwalk virus replication in replicon-bearing cells. J Virol 81:12111-12118. 
24. Collado, V.M., E. Gomez-Lucia, G. Tejerizo, G. Miro, E. Escolar, S. Martin, and 
A. Domenech. 2007. Effect of type I interferons on the expression of feline 
leukaemia virus. Vet Microbiol 123:180-186. 
25. Baize, S., D. Pannetier, C. Faure, P. Marianneau, I. Marendat, M.C. Georges-
Courbot, and V. Deubel. 2006. Role of interferons in the control of Lassa virus 
replication in human dendritic cells and macrophages. Microbes Infect 8:1194-
1202. 
26. Samuel, C.E. 2001. Antiviral actions of interferons. Clin Microbiol Rev 14:778-
809, table of contents. 
27. Haeryfar, S.M., and I. Berczi. 2001. The thymus and the acute phase response. 
Cell Mol Biol (Noisy-le-grand) 47:145-156. 
28. 1999. Correction: Acute-Phase Proteins and Other Systemic Responses to 
Inflammation. N Engl J Med 340:1376. 
29. Gabay, C., and I. Kushner. 1999. Acute-phase proteins and other systemic 
responses to inflammation. N Engl J Med 340:448-454. 
30. Winston, B.W., P.M. Krein, C. Mowat, and Y. Huang. 1999. Cytokine-induced 
macrophage differentiation: a tale of 2 genes. Clin Invest Med 22:236-255. 
31. Erridge, C. 2008. The roles of pathogen-associated molecular patterns in 
atherosclerosis. Trends Cardiovasc Med 18:52-56. 
32. Akira, S., and H. Hemmi. 2003. Recognition of pathogen-associated molecular 
patterns by TLR family. Immunol Lett 85:85-95. 
33. Tohya, K., E. Umemoto, and M. Miyasaka. 2010. Microanatomy of lymphocyte-
endothelial interactions at the high endothelial venules of lymph nodes. Histol 
Histopathol 25:781-794. 
34. von Andrian, U.H., and C. M'Rini. 1998. In situ analysis of lymphocyte migration 
to lymph nodes. Cell Adhes Commun 6:85-96. 
35. Lanzavecchia, A., and F. Sallusto. 2001. Regulation of T cell immunity by 
dendritic cells. Cell 106:263-266. 
36. Liu, Y.J. 2001. Dendritic cell subsets and lineages, and their functions in innate 
and adaptive immunity. Cell 106:259-262. 
37. Rothenberg, E.V. 1992. The development of functionally responsive T cells. Adv 
Immunol 51:85-214. 
38. Desiderio, S. 1994. The B cell antigen receptor in B-cell development. Curr Opin 
Immunol 6:248-256. 
 25 
39. Holst, P.J., C. Orskov, K. Qvortrup, J.P. Christensen, and A.R. Thomsen. 2007. 
CCR5 and CXCR3 are dispensable for liver infiltration, but CCR5 protects 
against virus-induced T-cell-mediated hepatic steatosis. J Virol 81:10101-10112. 
40. Chavez-Galan, L., M.C. Arenas-Del Angel, E. Zenteno, R. Chavez, and R. 
Lascurain. 2009. Cell death mechanisms induced by cytotoxic lymphocytes. Cell 
Mol Immunol 6:15-25. 
41. Bonecchi, R., G. Bianchi, P.P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, 
S. Sozzani, P. Allavena, P.A. Gray, A. Mantovani, and F. Sinigaglia. 1998. 
Differential expression of chemokine receptors and chemotactic responsiveness of 
type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129-134. 
42. Cole, K.E., C.A. Strick, T.J. Paradis, K.T. Ogborne, M. Loetscher, R.P. Gladue, 
W. Lin, J.G. Boyd, B. Moser, D.E. Wood, B.G. Sahagan, and K. Neote. 1998. 
Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC 
chemokine with potent activity on activated T cells through selective high affinity 
binding to CXCR3. J Exp Med 187:2009-2021. 
43. Kohlmeier, J.E., T. Cookenham, S.C. Miller, A.D. Roberts, J.P. Christensen, A.R. 
Thomsen, and D.L. Woodland. 2009. CXCR3 directs antigen-specific effector 
CD4+ T cell migration to the lung during parainfluenza virus infection. J 
Immunol 183:4378-4384. 
44. Uguccioni, M., C.R. Mackay, B. Ochensberger, P. Loetscher, S. Rhis, G.J. 
LaRosa, P. Rao, P.D. Ponath, M. Baggiolini, and C.A. Dahinden. 1997. High 
expression of the chemokine receptor CCR3 in human blood basophils. Role in 
activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 100:1137-
1143. 
45. Ponath, P.D., S. Qin, T.W. Post, J. Wang, L. Wu, N.P. Gerard, W. Newman, C. 
Gerard, and C.R. Mackay. 1996. Molecular cloning and characterization of a 
human eotaxin receptor expressed selectively on eosinophils. J Exp Med 
183:2437-2448. 
46. Wang, C., S.G. Kang, J. Lee, Z. Sun, and C.H. Kim. 2009. The roles of CCR6 in 
migration of Th17 cells and regulation of effector T-cell balance in the gut. 
Mucosal Immunol 2:173-183. 
47. King, C., S.G. Tangye, and C.R. Mackay. 2008. T follicular helper (TFH) cells in 
normal and dysregulated immune responses. Annu Rev Immunol 26:741-766. 
48. King, C. 2009. New insights into the differentiation and function of T follicular 
helper cells. Nat Rev Immunol 9:757-766. 
49. Reif, K., E.H. Ekland, L. Ohl, H. Nakano, M. Lipp, R. Forster, and J.G. Cyster. 
2002. Balanced responsiveness to chemoattractants from adjacent zones 
determines B-cell position. Nature 416:94-99. 
50. Cerutti, A., H. Zan, A. Schaffer, L. Bergsagel, N. Harindranath, E.E. Max, and P. 
Casali. 1998. CD40 ligand and appropriate cytokines induce switching to IgG, 
IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic 
differentiation in a human monoclonal IgM+IgD+ B cell line. J Immunol 
160:2145-2157. 
51. Gemmell, E., and G.J. Seymour. 1994. Cytokines and T cell switching. Crit Rev 
Oral Biol Med 5:249-279. 
 26 
52. Fagarasan, S., S. Kawamoto, O. Kanagawa, and K. Suzuki. 2010. Adaptive 
immune regulation in the gut: T cell-dependent and T cell-independent IgA 
synthesis. Annu Rev Immunol 28:243-273. 
53. Iwasaki, A., and R. Medzhitov. 2010. Regulation of adaptive immunity by the 
innate immune system. Science 327:291-295. 
54. Schoenborn, J.R., and C.B. Wilson. 2007. Regulation of interferon-gamma during 
innate and adaptive immune responses. Adv Immunol 96:41-101. 
55. DeKruyff, R.H., L.V. Rizzo, and D.T. Umetsu. 1993. Induction of 
immunoglobulin synthesis by CD4+ T cell clones. Semin Immunol 5:421-430. 
56. Weaver, C.T., L.E. Harrington, P.R. Mangan, M. Gavrieli, and K.M. Murphy. 
2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 
24:677-688. 
57. Kurts, C. 2008. Th17 cells: a third subset of CD4+ T effector cells involved in 
organ-specific autoimmunity. Nephrol Dial Transplant 23:816-819. 
58. Miossec, P. 2009. IL-17 and Th17 cells in human inflammatory diseases. 
Microbes Infect 11:625-630. 
59. Korn, T., E. Bettelli, M. Oukka, and V.K. Kuchroo. 2009. IL-17 and Th17 Cells. 
Annu Rev Immunol 27:485-517. 
60. Badovinac, V.P., and J.T. Harty. 2002. CD8(+) T-cell homeostasis after infection: 
setting the 'curve'. Microbes Infect 4:441-447. 
61. Campos, M., and D.L. Godson. 2003. The effectiveness and limitations of 
immune memory: understanding protective immune responses. Int J Parasitol 
33:655-661. 
62. Harty, J.T., and V.P. Badovinac. 2008. Shaping and reshaping CD8+ T-cell 
memory. Nat Rev Immunol 8:107-119. 
63. Williams, M.A., and M.J. Bevan. 2007. Effector and memory CTL differentiation. 
Annu Rev Immunol 25:171-192. 
64. Oehen, S., and K. Brduscha-Riem. 1998. Differentiation of naive CTL to effector 
and memory CTL: correlation of effector function with phenotype and cell 
division. J Immunol 161:5338-5346. 
65. Brandtzaeg, P. 2007. Induction of secretory immunity and memory at mucosal 
surfaces. Vaccine 25:5467-5484. 
66. Manz, R.A., S. Arce, G. Cassese, A.E. Hauser, F. Hiepe, and A. Radbruch. 2002. 
Humoral immunity and long-lived plasma cells. Curr Opin Immunol 14:517-521. 
67. Hofer, T., G. Muehlinghaus, K. Moser, T. Yoshida, E.M. H, K. Hebel, A. Hauser, 
B. Hoyer, O.L. E, T. Dorner, R.A. Manz, F. Hiepe, and A. Radbruch. 2006. 
Adaptation of humoral memory. Immunol Rev 211:295-302. 
68. Manz, R.A., A.E. Hauser, F. Hiepe, and A. Radbruch. 2005. Maintenance of 
serum antibody levels. Annu Rev Immunol 23:367-386. 
69. Bernasconi, N.L., E. Traggiai, and A. Lanzavecchia. 2002. Maintenance of 
serological memory by polyclonal activation of human memory B cells. Science 
298:2199-2202. 
70. DiLillo, D.J., Y. Hamaguchi, Y. Ueda, K. Yang, J. Uchida, K.M. Haas, G. Kelsoe, 
and T.F. Tedder. 2008. Maintenance of long-lived plasma cells and serological 
memory despite mature and memory B cell depletion during CD20 
immunotherapy in mice. J Immunol 180:361-371. 
 27 
71. Wrammert, J., and R. Ahmed. 2008. Maintenance of serological memory. Biol 
Chem 389:537-539. 
72. Osborne, L.C., S. Dhanji, J.W. Snow, J.J. Priatel, M.C. Ma, M.J. Miners, H.S. 
Teh, M.A. Goldsmith, and N. Abraham. 2007. Impaired CD8 T cell memory and 
CD4 T cell primary responses in IL-7R alpha mutant mice. J Exp Med 204:619-
631. 
73. Carrio, R., C.E. Rolle, and T.R. Malek. 2007. Non-redundant role for IL-7R 
signaling for the survival of CD8+ memory T cells. Eur J Immunol 37:3078-3088. 
74. Becker, T.C., E.J. Wherry, D. Boone, K. Murali-Krishna, R. Antia, A. Ma, and R. 
Ahmed. 2002. Interleukin 15 is required for proliferative renewal of virus-specific 
memory CD8 T cells. J Exp Med 195:1541-1548. 
75. Judge, A.D., X. Zhang, H. Fujii, C.D. Surh, and J. Sprent. 2002. Interleukin 15 
controls both proliferation and survival of a subset of memory-phenotype CD8(+) 
T cells. J Exp Med 196:935-946. 
76. Boyman, O., S. Letourneau, C. Krieg, and J. Sprent. 2009. Homeostatic 
proliferation and survival of naive and memory T cells. Eur J Immunol 39:2088-
2094. 
77. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector 
memory T cell subsets: function, generation, and maintenance. Annu Rev 
Immunol 22:745-763. 
78. Campbell, J.J., E.P. Bowman, K. Murphy, K.R. Youngman, M.A. Siani, D.A. 
Thompson, L. Wu, A. Zlotnik, and E.C. Butcher. 1998. 6-C-kine (SLC), a 
lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an 
agonist for the MIP-3beta receptor CCR7. J Cell Biol 141:1053-1059. 
79. Forster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Muller, E. Wolf, and 
M. Lipp. 1999. CCR7 coordinates the primary immune response by establishing 
functional microenvironments in secondary lymphoid organs. Cell 99:23-33. 
80. Bachmann, M.F., M. Barner, A. Viola, and M. Kopf. 1999. Distinct kinetics of 
cytokine production and cytolysis in effector and memory T cells after viral 
infection. Eur J Immunol 29:291-299. 
81. Kaech, S.M., and R. Ahmed. 2001. Memory CD8+ T cell differentiation: initial 
antigen encounter triggers a developmental program in naive cells. Nat Immunol 
2:415-422. 
82. Duttagupta, P.A., A.C. Boesteanu, and P.D. Katsikis. 2009. Costimulation signals 
for memory CD8+ T cells during viral infections. Crit Rev Immunol 29:469-486. 
83. Bullock, T.N., T.A. Colella, and V.H. Engelhard. 2000. The density of peptides 
displayed by dendritic cells affects immune responses to human tyrosinase and 
gp100 in HLA-A2 transgenic mice. J Immunol 164:2354-2361. 
84. Wherry, E.J., K.A. Puorro, A. Porgador, and L.C. Eisenlohr. 1999. The induction 
of virus-specific CTL as a function of increasing epitope expression: responses 
rise steadily until excessively high levels of epitope are attained. J Immunol 
163:3735-3745. 
85. Greenwald, R.J., G.J. Freeman, and A.H. Sharpe. 2005. The B7 family revisited. 
Annu Rev Immunol 23:515-548. 
86. Watts, T.H. 2005. TNF/TNFR family members in costimulation of T cell 
responses. Annu Rev Immunol 23:23-68. 
 28 
87. Maxwell, J.R., J.D. Campbell, C.H. Kim, and A.T. Vella. 1999. CD40 activation 
boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying 
peripheral T cell deletion. J Immunol 162:2024-2034. 
88. Maxwell, J.R., A. Weinberg, R.A. Prell, and A.T. Vella. 2000. Danger and OX40 
receptor signaling synergize to enhance memory T cell survival by inhibiting 
peripheral deletion. J Immunol 164:107-112. 
89. Hendriks, J., L.A. Gravestein, K. Tesselaar, R.A. van Lier, T.N. Schumacher, and 
J. Borst. 2000. CD27 is required for generation and long-term maintenance of T 
cell immunity. Nat Immunol 1:433-440. 
90. Jelley-Gibbs, D.M., T.M. Strutt, K.K. McKinstry, and S.L. Swain. 2008. 
Influencing the fates of CD4 T cells on the path to memory: lessons from 
influenza. Immunol Cell Biol 86:343-352. 
91. Rodrigues, L., and C. Bonorino. 2009. Role of IL-15 and IL-21 in viral immunity: 
applications for vaccines and therapies. Expert Rev Vaccines 8:167-177. 
92. Williams, M.A., A.J. Tyznik, and M.J. Bevan. 2006. Interleukin-2 signals during 
priming are required for secondary expansion of CD8+ memory T cells. Nature 
441:890-893. 
93. Pearce, E.L., and H. Shen. 2007. Generation of CD8 T cell memory is regulated 
by IL-12. J Immunol 179:2074-2081. 
94. Badovinac, V.P., and J.T. Harty. 2007. Manipulating the rate of memory CD8+ T 
cell generation after acute infection. J Immunol 179:53-63. 
95. Rocha, B., and C. Tanchot. 2004. Towards a cellular definition of CD8+ T-cell 
memory: the role of CD4+ T-cell help in CD8+ T-cell responses. Curr Opin 
Immunol 16:259-263. 
96. Bourgeois, C., and C. Tanchot. 2003. Mini-review CD4 T cells are required for 
CD8 T cell memory generation. Eur J Immunol 33:3225-3231. 
97. Nossal, G.J. 1997. B lymphocyte physiology: the beginning and the end. Ciba 
Found Symp 204:220-230; discussion 230-221. 
98. Bourgeois, C., B. Rocha, and C. Tanchot. 2002. A role for CD40 expression on 
CD8+ T cells in the generation of CD8+ T cell memory. Science 297:2060-2063. 
99. Castellino, F., A.Y. Huang, G. Altan-Bonnet, S. Stoll, C. Scheinecker, and R.N. 
Germain. 2006. Chemokines enhance immunity by guiding naive CD8+ T cells to 
sites of CD4+ T cell-dendritic cell interaction. Nature 440:890-895. 
100. Sun, J.C., M.A. Williams, and M.J. Bevan. 2004. CD4+ T cells are required for 
the maintenance, not programming, of memory CD8+ T cells after acute 
infection. Nat Immunol 5:927-933. 
101. Ciofani, M., and J.C. Zuniga-Pflucker. 2006. A survival guide to early T cell 
development. Immunol Res 34:117-132. 
102. Bonnet, M., P. Ferrier, and S. Spicuglia. 2009. Molecular genetics at the T-cell 
receptor beta locus: insights into the regulation of V(D)J recombination. Adv Exp 
Med Biol 650:116-132. 
103. Michie, A.M., and J.C. Zuniga-Pflucker. 2002. Regulation of thymocyte 
differentiation: pre-TCR signals and beta-selection. Semin Immunol 14:311-323. 
104. Aifantis, I., M. Mandal, K. Sawai, A. Ferrando, and T. Vilimas. 2006. Regulation 
of T-cell progenitor survival and cell-cycle entry by the pre-T-cell receptor. 
Immunol Rev 209:159-169. 
 29 
105. Marrack, P., and J. Kappler. 1997. Positive selection of thymocytes bearing alpha 
beta T cell receptors. Curr Opin Immunol 9:250-255. 
106. Kisielow, P., H.S. Teh, H. Bluthmann, and H. von Boehmer. 1988. Positive 
selection of antigen-specific T cells in thymus by restricting MHC molecules. 
Nature 335:730-733. 
107. Starr, T.K., S.C. Jameson, and K.A. Hogquist. 2003. Positive and negative 
selection of T cells. Annu Rev Immunol 21:139-176. 
108. Garcia, K.C., L. Teyton, and I.A. Wilson. 1999. Structural basis of T cell 
recognition. Annu Rev Immunol 17:369-397. 
109. Palmer, E. 2003. Negative selection--clearing out the bad apples from the T-cell 
repertoire. Nat Rev Immunol 3:383-391. 
110. Chen, W. 2004. The late stage of T cell development within mouse thymus. Cell 
Mol Immunol 1:3-11. 
111. Sohn, S.J., J. Thompson, and A. Winoto. 2007. Apoptosis during negative 
selection of autoreactive thymocytes. Curr Opin Immunol 19:510-515. 
112. Peterson, P., T. Org, and A. Rebane. 2008. Transcriptional regulation by AIRE: 
molecular mechanisms of central tolerance. Nat Rev Immunol 8:948-957. 
113. Ashwell, J.D., and R.D. Klusner. 1990. Genetic and mutational analysis of the T-
cell antigen receptor. Annu Rev Immunol 8:139-167. 
114. Dustin, M.L., and A.C. Chan. 2000. Signaling takes shape in the immune system. 
Cell 103:283-294. 
115. Germain, R.N. 2001. The T cell receptor for antigen: signaling and ligand 
discrimination. J Biol Chem 276:35223-35226. 
116. Samelson, L.E., M.D. Patel, A.M. Weissman, J.B. Harford, and R.D. Klausner. 
1986. Antigen activation of murine T cells induces tyrosine phosphorylation of a 
polypeptide associated with the T cell antigen receptor. Cell 46:1083-1090. 
117. Samelson, L.E., A.F. Phillips, E.T. Luong, and R.D. Klausner. 1990. Association 
of the fyn protein-tyrosine kinase with the T-cell antigen receptor. Proc Natl Acad 
Sci U S A 87:4358-4362. 
118. Straus, D.B., and A. Weiss. 1992. Genetic evidence for the involvement of the lck 
tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 
70:585-593. 
119. Gauen, L.K., Y. Zhu, F. Letourneur, Q. Hu, J.B. Bolen, L.A. Matis, R.D. 
Klausner, and A.S. Shaw. 1994. Interactions of p59fyn and ZAP-70 with T-cell 
receptor activation motifs: defining the nature of a signalling motif. Mol Cell Biol 
14:3729-3741. 
120. Iwashima, M., B.A. Irving, N.S. van Oers, A.C. Chan, and A. Weiss. 1994. 
Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. 
Science 263:1136-1139. 
121. Chan, A.C., M. Dalton, R. Johnson, G.H. Kong, T. Wang, R. Thoma, and T. 
Kurosaki. 1995. Activation of ZAP-70 kinase activity by phosphorylation of 
tyrosine 493 is required for lymphocyte antigen receptor function. EMBO J 
14:2499-2508. 
122. Neumeister, E.N., Y. Zhu, S. Richard, C. Terhorst, A.C. Chan, and A.S. Shaw. 
1995. Binding of ZAP-70 to phosphorylated T-cell receptor zeta and eta enhances 
 30 
its autophosphorylation and generates specific binding sites for SH2 domain-
containing proteins. Mol Cell Biol 15:3171-3178. 
123. Jackman, J.K., D.G. Motto, Q. Sun, M. Tanemoto, C.W. Turck, G.A. Peltz, G.A. 
Koretzky, and P.R. Findell. 1995. Molecular cloning of SLP-76, a 76-kDa 
tyrosine phosphoprotein associated with Grb2 in T cells. J Biol Chem 270:7029-
7032. 
124. Zhang, W., J. Sloan-Lancaster, J. Kitchen, R.P. Trible, and L.E. Samelson. 1998. 
LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular 
activation. Cell 92:83-92. 
125. Bunnell, S.C., M. Diehn, M.B. Yaffe, P.R. Findell, L.C. Cantley, and L.J. Berg. 
2000. Biochemical interactions integrating Itk with the T cell receptor-initiated 
signaling cascade. J Biol Chem 275:2219-2230. 
126. Bubeck Wardenburg, J., R. Pappu, J.Y. Bu, B. Mayer, J. Chernoff, D. Straus, and 
A.C. Chan. 1998. Regulation of PAK activation and the T cell cytoskeleton by the 
linker protein SLP-76. Immunity 9:607-616. 
127. Su, Y.W., Y. Zhang, J. Schweikert, G.A. Koretzky, M. Reth, and J. Wienands. 
1999. Interaction of SLP adaptors with the SH2 domain of Tec family kinases. 
Eur J Immunol 29:3702-3711. 
128. Prince, A.L., C.C. Yin, M.E. Enos, M. Felices, and L.J. Berg. 2009. The Tec 
kinases Itk and Rlk regulate conventional versus innate T-cell development. 
Immunol Rev 228:115-131. 
129. Wu, J., D.G. Motto, G.A. Koretzky, and A. Weiss. 1996. Vav and SLP-76 interact 
and functionally cooperate in IL-2 gene activation. Immunity 4:593-602. 
130. Raab, M., A.J. da Silva, P.R. Findell, and C.E. Rudd. 1997. Regulation of Vav-
SLP-76 binding by ZAP-70 and its relevance to TCR zeta/CD3 induction of 
interleukin-2. Immunity 6:155-164. 
131. Yablonski, D., M.R. Kuhne, T. Kadlecek, and A. Weiss. 1998. Uncoupling of 
nonreceptor tyrosine kinases from PLC-gamma1 in an SLP-76-deficient T cell. 
Science 281:413-416. 
132. Liu, K.Q., S.C. Bunnell, C.B. Gurniak, and L.J. Berg. 1998. T cell receptor-
initiated calcium release is uncoupled from capacitative calcium entry in Itk-
deficient T cells. J Exp Med 187:1721-1727. 
133. Takeuchi, K., M.H. Roehrl, Z.Y. Sun, and G. Wagner. 2007. Structure of the 
calcineurin-NFAT complex: defining a T cell activation switch using solution 
NMR and crystal coordinates. Structure 15:587-597. 
134. Jain, J., C. Loh, and A. Rao. 1995. Transcriptional regulation of the IL-2 gene. 
Curr Opin Immunol 7:333-342. 
135. Karin, M., Z. Liu, and E. Zandi. 1997. AP-1 function and regulation. Curr Opin 
Cell Biol 9:240-246. 
136. Altman, A., and M. Villalba. 2002. Protein kinase C-theta (PKC theta): a key 
enzyme in T cell life and death. J Biochem 132:841-846. 
137. Alberola-Ila, J., and G. Hernandez-Hoyos. 2003. The Ras/MAPK cascade and the 
control of positive selection. Immunol Rev 191:79-96. 
138. Juntilla, M.M., and G.A. Koretzky. 2008. Critical roles of the PI3K/Akt signaling 
pathway in T cell development. Immunol Lett 116:104-110. 
 31 
139. Wang, C.R., K. Hashimoto, S. Kubo, T. Yokochi, M. Kubo, M. Suzuki, K. 
Suzuki, T. Tada, and T. Nakayama. 1995. T cell receptor-mediated signaling 
events in CD4+CD8+ thymocytes undergoing thymic selection: requirement of 
calcineurin activation for thymic positive selection but not negative selection. J 
Exp Med 181:927-941. 
140. Oukka, M., I.C. Ho, F.C. de la Brousse, T. Hoey, M.J. Grusby, and L.H. 
Glimcher. 1998. The transcription factor NFAT4 is involved in the generation and 
survival of T cells. Immunity 9:295-304. 
141. Neilson, J.R., M.M. Winslow, E.M. Hur, and G.R. Crabtree. 2004. Calcineurin B1 
is essential for positive but not negative selection during thymocyte development. 
Immunity 20:255-266. 
142. Hayden-Martinez, K., L.P. Kane, and S.M. Hedrick. 2000. Effects of a 
constitutively active form of calcineurin on T cell activation and thymic selection. 
J Immunol 165:3713-3721. 
143. Dower, N.A., S.L. Stang, D.A. Bottorff, J.O. Ebinu, P. Dickie, H.L. Ostergaard, 
and J.C. Stone. 2000. RasGRP is essential for mouse thymocyte differentiation 
and TCR signaling. Nat Immunol 1:317-321. 
144. Swan, K.A., J. Alberola-Ila, J.A. Gross, M.W. Appleby, K.A. Forbush, J.F. 
Thomas, and R.M. Perlmutter. 1995. Involvement of p21ras distinguishes positive 
and negative selection in thymocytes. EMBO J 14:276-285. 
145. Alberola-Ila, J., K.A. Forbush, R. Seger, E.G. Krebs, and R.M. Perlmutter. 1995. 
Selective requirement for MAP kinase activation in thymocyte differentiation. 
Nature 373:620-623. 
146. Alberola-Ila, J., K.A. Hogquist, K.A. Swan, M.J. Bevan, and R.M. Perlmutter. 
1996. Positive and negative selection invoke distinct signaling pathways. J Exp 
Med 184:9-18. 
147. Pages, G., S. Guerin, D. Grall, F. Bonino, A. Smith, F. Anjuere, P. Auberger, and 
J. Pouyssegur. 1999. Defective thymocyte maturation in p44 MAP kinase (Erk 1) 
knockout mice. Science 286:1374-1377. 
148. Shao, H., D.H. Kono, L.Y. Chen, E.M. Rubin, and J. Kaye. 1997. Induction of the 
early growth response (Egr) family of transcription factors during thymic 
selection. J Exp Med 185:731-744. 
149. Miyazaki, T., and F.A. Lemonnier. 1998. Modulation of thymic selection by 
expression of an immediate-early gene, early growth response 1 (Egr-1). J Exp 
Med 188:715-723. 
150. Cuevas, B.D., A.N. Abell, and G.L. Johnson. 2007. Role of mitogen-activated 
protein kinase kinase kinases in signal integration. Oncogene 26:3159-3171. 
151. Bivona, T.G., I. Perez De Castro, I.M. Ahearn, T.M. Grana, V.K. Chiu, P.J. 
Lockyer, P.J. Cullen, A. Pellicer, A.D. Cox, and M.R. Philips. 2003. 
Phospholipase Cgamma activates Ras on the Golgi apparatus by means of 
RasGRP1. Nature 424:694-698. 
152. Harding, A., T. Tian, E. Westbury, E. Frische, and J.F. Hancock. 2005. 
Subcellular localization determines MAP kinase signal output. Curr Biol 15:869-
873. 
153. Mor, A., and M.R. Philips. 2006. Compartmentalized Ras/MAPK signaling. Annu 
Rev Immunol 24:771-800. 
 32 
154. Daniels, M.A., E. Teixeiro, J. Gill, B. Hausmann, D. Roubaty, K. Holmberg, G. 
Werlen, G.A. Hollander, N.R. Gascoigne, and E. Palmer. 2006. Thymic selection 
threshold defined by compartmentalization of Ras/MAPK signalling. Nature 
444:724-729. 
155. Bommhardt, U., Y. Scheuring, C. Bickel, R. Zamoyska, and T. Hunig. 2000. 
MEK activity regulates negative selection of immature CD4+CD8+ thymocytes. J 
Immunol 164:2326-2337. 
156. Gong, Q., A.M. Cheng, A.M. Akk, J. Alberola-Ila, G. Gong, T. Pawson, and A.C. 
Chan. 2001. Disruption of T cell signaling networks and development by Grb2 
haploid insufficiency. Nat Immunol 2:29-36. 
157. Sabapathy, K., Y. Hu, T. Kallunki, M. Schreiber, J.P. David, W. Jochum, E.F. 
Wagner, and M. Karin. 1999. JNK2 is required for efficient T-cell activation and 
apoptosis but not for normal lymphocyte development. Curr Biol 9:116-125. 
158. Sabapathy, K., T. Kallunki, J.P. David, I. Graef, M. Karin, and E.F. Wagner. 
2001. c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-
dependent roles in regulating T cell apoptosis and proliferation. J Exp Med 
193:317-328. 
159. Kurasawa, K., Y. Hashimoto, M. Kasai, and I. Iwamoto. 2000. The fas antigen is 
involved in thymic T-cell development as a costimulatory molecule, but not in the 
deletion of neglected thymocytes. J Allergy Clin Immunol 106:S19-31. 
160. Bouillet, P., J.F. Purton, D.I. Godfrey, L.C. Zhang, L. Coultas, H. Puthalakath, M. 
Pellegrini, S. Cory, J.M. Adams, and A. Strasser. 2002. BH3-only Bcl-2 family 
member Bim is required for apoptosis of autoreactive thymocytes. Nature 
415:922-926. 
161. Villunger, A., V.S. Marsden, Y. Zhan, M. Erlacher, A.M. Lew, P. Bouillet, S. 
Berzins, D.I. Godfrey, W.R. Heath, and A. Strasser. 2004. Negative selection of 
semimature CD4(+)8(-)HSA+ thymocytes requires the BH3-only protein Bim but 
is independent of death receptor signaling. Proc Natl Acad Sci U S A 101:7052-
7057. 
162. Calnan, B.J., S. Szychowski, F.K. Chan, D. Cado, and A. Winoto. 1995. A role 
for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced 
negative selection. Immunity 3:273-282. 
163. Markert, M.L., M.J. Alexieff, J. Li, M. Sarzotti, D.A. Ozaki, B.H. Devlin, D.A. 
Sedlak, G.D. Sempowski, L.P. Hale, H.E. Rice, S.M. Mahaffey, and M.A. 
Skinner. 2004. Postnatal thymus transplantation with immunosuppression as 
treatment for DiGeorge syndrome. Blood 104:2574-2581. 
164. Thulesen, S., A. Jorgensen, J. Gerwien, M. Dohlsten, M. Holst Nissen, N. Odum, 
and C. Ropke. 1999. Superantigens are presented by and activate thymocytes 
from infants. Exp Clin Immunogenet 16:226-233. 
165. Godthelp, B.C., M.C. Van Eggermond, M.J. Van Tol, J.M. Vossen, and P.J. van 
den Elsen. 2000. T cell immune reconstitution after allogeneic bone marrow 
transplantation in bare lymphocyte syndrome. Hum Immunol 61:898-907. 
166. Klein, C., M. Cavazzana-Calvo, F. Le Deist, N. Jabado, M. Benkerrou, S. 
Blanche, B. Lisowska-Grospierre, C. Griscelli, and A. Fischer. 1995. Bone 
marrow transplantation in major histocompatibility complex class II deficiency: a 
single-center study of 19 patients. Blood 85:580-587. 
 33 
167. Van Coppernolle, S., G. Verstichel, F. Timmermans, I. Velghe, D. Vermijlen, M. 
De Smedt, G. Leclercq, J. Plum, T. Taghon, B. Vandekerckhove, and T. Kerre. 
2009. Functionally mature CD4 and CD8 TCRalphabeta cells are generated in 
OP9-DL1 cultures from human CD34+ hematopoietic cells. J Immunol 183:4859-
4870. 
168. Park, S.H., Y.M. Bae, T.J. Kim, I.S. Ha, S. Kim, J.G. Chi, and S.K. Lee. 1992. 
HLA-DR expression in human fetal thymocytes. Hum Immunol 33:294-298. 
169. Marinova, T., I. Altankova, D. Dimitrova, and Y. Pomakov. 2001. Presence of 
HLA-DR immunopositive cells in human fetal thymus. Arch Physiol Biochem 
109:74-79. 
170. Lee, Y.J., Y.K. Jeon, B.H. Kang, D.H. Chung, C.G. Park, H.Y. Shin, K.C. Jung, 
and S.H. Park. 2009. Generation of PLZF+ CD4+ T cells via MHC class II-
dependent thymocyte-thymocyte interaction is a physiological process in humans. 
J Exp Med  
171. Li, W., M.G. Kim, T.S. Gourley, B.P. McCarthy, D.B. Sant'Angelo, and C.H. 
Chang. 2005. An alternate pathway for CD4 T cell development: thymocyte-
expressed MHC class II selects a distinct T cell population. Immunity 23:375-386. 
172. Choi, E.Y., K.C. Jung, H.J. Park, D.H. Chung, J.S. Song, S.D. Yang, E. Simpson, 
and S.H. Park. 2005. Thymocyte-thymocyte interaction for efficient positive 
selection and maturation of CD4 T cells. Immunity 23:387-396. 
173. Engel, P., M.J. Eck, and C. Terhorst. 2003. The SAP and SLAM families in 
immune responses and X-linked lymphoproliferative disease. Nat Rev Immunol 
3:813-821. 
174. Cannons, J.L., H. Qi, K.T. Lu, M. Dutta, J. Gomez-Rodriguez, J. Cheng, E.K. 
Wakeland, R.N. Germain, and P.L. Schwartzberg. 2010. Optimal germinal center 
responses require a multistage T cell:B cell adhesion process involving integrins, 
SLAM-associated protein, and CD84. Immunity 32:253-265. 
175. Li, W., M.H. Sofi, S. Rietdijk, N. Wang, C. Terhorst, and C.H. Chang. 2007. The 
SLAM-associated protein signaling pathway is required for development of CD4+ 
T cells selected by homotypic thymocyte interaction. Immunity 27:763-774. 
176. Li, W., M.H. Sofi, N. Yeh, S. Sehra, B.P. McCarthy, D.R. Patel, R.R. 
Brutkiewicz, M.H. Kaplan, and C.H. Chang. 2007. Thymic selection pathway 
regulates the effector function of CD4 T cells. J Exp Med 204:2145-2157. 
177. Dieli, F., M. Taniguchi, M. Kronenberg, S. Sidobre, J. Ivanyi, L. Fattorini, E. 
Iona, G. Orefici, G. De Leo, D. Russo, N. Caccamo, G. Sireci, C. Di Sano, and A. 
Salerno. 2003. An anti-inflammatory role for V alpha 14 NK T cells in 
Mycobacterium bovis bacillus Calmette-Guerin-infected mice. J Immunol 
171:1961-1968. 
178. Park, W.S., Y. Bae, D.H. Chung, Y.L. Choi, B.K. Kim, Y.C. Sung, E.Y. Choi, 
S.H. Park, and K.C. Jung. 2004. T cell expression of CIITA represses Th1 
immunity. Int Immunol 16:1355-1364. 
179. Kim, T.W., H.J. Park, E.Y. Choi, and K.C. Jung. 2006. Overexpression of CIITA 
in T cells aggravates Th2-mediated colitis in mice. J Korean Med Sci 21:877-882. 
180. Bendelac, A., M.N. Rivera, S.H. Park, and J.H. Roark. 1997. Mouse CD1-specific 
NK1 T cells: development, specificity, and function. Annu Rev Immunol 15:535-
562. 
 34 
181. MacDonald, H.R. 1995. NK1.1+ T cell receptor-alpha/beta+ cells: new clues to 
their origin, specificity, and function. J Exp Med 182:633-638. 
182. Wilson, S.B., and T.L. Delovitch. 2003. Janus-like role of regulatory iNKT cells 
in autoimmune disease and tumour immunity. Nat Rev Immunol 3:211-222. 
183. Moodycliffe, A.M., D. Nghiem, G. Clydesdale, and S.E. Ullrich. 2000. Immune 
suppression and skin cancer development: regulation by NKT cells. Nat Immunol 
1:521-525. 
184. Taniguchi, M., K. Seino, and T. Nakayama. 2003. The NKT cell system: bridging 
innate and acquired immunity. Nat Immunol 4:1164-1165. 
185. Porcelli, S.A., and R.L. Modlin. 1999. The CD1 system: antigen-presenting 
molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 
17:297-329. 
186. Brossay, L., and M. Kronenberg. 1999. Highly conserved antigen-presenting 
function of CD1d molecules. Immunogenetics 50:146-151. 
187. Godfrey, D.I., S. Stankovic, and A.G. Baxter. 2010. Raising the NKT cell family. 
Nat Immunol 11:197-206. 
188. Griewank, K., C. Borowski, S. Rietdijk, N. Wang, A. Julien, D.G. Wei, A.A. 
Mamchak, C. Terhorst, and A. Bendelac. 2007. Homotypic interactions mediated 
by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 
27:751-762. 
189. Kerksiek, K.M., D.H. Busch, I.M. Pilip, S.E. Allen, and E.G. Pamer. 1999. H2-
M3-restricted T cells in bacterial infection: rapid primary but diminished memory 
responses. J Exp Med 190:195-204. 
190. Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT cells. 
Nat Rev Immunol 2:557-568. 
191. Gibbings, D., and A.D. Befus. 2009. CD4 and CD8: an inside-out coreceptor 
model for innate immune cells. J Leukoc Biol 86:251-259. 
192. Huang, Y., H. Rabb, and K.L. Womer. 2007. Ischemia-reperfusion and immediate 
T cell responses. Cell Immunol 248:4-11. 
193. Stewart, V.A., S. McGrath, A.M. Krieg, N.S. Larson, E. Angov, C.L. Smith, T.G. 
Brewer, and D.G. Heppner, Jr. 2008. Activation of innate immunity in healthy 
Macaca mulatta macaques by a single subcutaneous dose of GMP CpG 7909: 
safety data and interferon-inducible protein-10 kinetics for humans and macaques. 
Clin Vaccine Immunol 15:221-226. 
194. Le Page, C., P. Genin, M.G. Baines, and J. Hiscott. 2000. Interferon activation 
and innate immunity. Rev Immunogenet 2:374-386. 
195. Berg, L.J. 2007. Signalling through TEC kinases regulates conventional versus 
innate CD8(+) T-cell development. Nat Rev Immunol 7:479-485. 
196. Dhanji, S., S.J. Teh, D. Oble, J.J. Priatel, and H.S. Teh. 2004. Self-reactive 
memory-phenotype CD8 T cells exhibit both MHC-restricted and non-MHC-
restricted cytotoxicity: a role for the T-cell receptor and natural killer cell 
receptors. Blood 104:2116-2123. 
197. Lertmemongkolchai, G., G. Cai, C.A. Hunter, and G.J. Bancroft. 2001. Bystander 
activation of CD8+ T cells contributes to the rapid production of IFN-gamma in 
response to bacterial pathogens. J Immunol 166:1097-1105. 
 35 
198. Raue, H.P., J.D. Brien, E. Hammarlund, and M.K. Slifka. 2004. Activation of 
virus-specific CD8+ T cells by lipopolysaccharide-induced IL-12 and IL-18. J 
Immunol 173:6873-6881. 
199. Horai, R., K.L. Mueller, R.A. Handon, J.L. Cannons, S.M. Anderson, M.R. Kirby, 
and P.L. Schwartzberg. 2007. Requirements for selection of conventional and 
innate T lymphocyte lineages. Immunity 27:775-785. 
200. Loveland, B., C.R. Wang, H. Yonekawa, E. Hermel, and K.F. Lindahl. 1990. 
Maternally transmitted histocompatibility antigen of mice: a hydrophobic peptide 
of a mitochondrially encoded protein. Cell 60:971-980. 
201. Gangadharan, D., and H. Cheroutre. 2004. The CD8 isoform CD8alphaalpha is 
not a functional homologue of the TCR co-receptor CD8alphabeta. Curr Opin 
Immunol 16:264-270. 
202. Yamagata, T., D. Mathis, and C. Benoist. 2004. Self-reactivity in thymic double-
positive cells commits cells to a CD8 alpha alpha lineage with characteristics of 
innate immune cells. Nat Immunol 5:597-605. 
203. Ploss, A., A. Tran, E. Menet, I. Leiner, and E.G. Pamer. 2005. Cross-recognition 
of N-formylmethionine peptides is a general characteristic of H2-M3-restricted 
CD8+ T cells. Infect Immun 73:4423-4426. 
204. Lawrence, L.M., and A. Gilmour. 1995. Characterization of Listeria 
monocytogenes isolated from poultry products and from the poultry-processing 
environment by random amplification of polymorphic DNA and multilocus 
enzyme electrophoresis. Appl Environ Microbiol 61:2139-2144. 
205. Gilot, P., and P. Andre. 1995. Characterization of five esterases from Listeria 
monocytogenes and use of their electrophoretic polymorphism for strain typing. 
Appl Environ Microbiol 61:1661-1665. 
206. Belyi Iu, F., L.A. Karpova, O.I. Barkhatova, I.S. Tartakovskii, and S.V. 
Prozorovskii. 1995. [The isolation and partial characterization of the cell wall 
proteins of Listeria monocytogenes]. Zh Mikrobiol Epidemiol Immunobiol 15-18. 
207. Xiong, H., Y. Tanabe, S. Ohya, and M. Mitsuyama. 1998. Administration of 
killed bacteria together with listeriolysin O induces protective immunity against 
Listeria monocytogenes in mice. Immunology 94:14-21. 
208. Nomura, A., G. Matsuzaki, H. Takada, K. Hiromatsu, S. Nabeshima, T. 
Nakamura, K. Kishihara, and K. Nomoto. 1998. The role of gammadelta T cells 
in induction of bacterial antigen-specific protective CD8+ cytotoxic T cells in 
immune response against the intracellular bacteria Listeria monocytogenes. 
Immunology 95:226-233. 
209. Schillinger, U., H.S. Chung, K. Keppler, and W.H. Holzapfel. 1998. Use of 
bacteriocinogenic lactic acid bacteria to inhibit spontaneous nisin-resistant 
mutants of Listeria monocytogenes Scott A. J Appl Microbiol 85:657-663. 
210. Nataraj, C., G.R. Huffman, and R.J. Kurlander. 1998. H2M3wt-restricted, Listeria 
monocytogenes-immune CD8 T cells respond to multiple formylated peptides and 
to a variety of gram-positive and gram-negative bacteria. Int Immunol 10:7-15. 
211. Miller, M.A., M.J. Skeen, and H.K. Ziegler. 1995. Nonviable bacterial antigens 
administered with IL-12 generate antigen-specific T cell responses and protective 
immunity against Listeria monocytogenes. J Immunol 155:4817-4828. 
 36 
212. Harty, J.T., and M.J. Bevan. 1995. Specific immunity to Listeria monocytogenes 
in the absence of IFN gamma. Immunity 3:109-117. 
213. Shen, H., M.K. Slifka, M. Matloubian, E.R. Jensen, R. Ahmed, and J.F. Miller. 
1995. Recombinant Listeria monocytogenes as a live vaccine vehicle for the 
induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci U S 
A 92:3987-3991. 
214. Rosen, H., S. Gordon, and R.J. North. 1989. Exacerbation of murine listeriosis by 
a monoclonal antibody specific for the type 3 complement receptor of 
myelomonocytic cells. Absence of monocytes at infective foci allows Listeria to 
multiply in nonphagocytic cells. J Exp Med 170:27-37. 
215. Kurihara, T., G. Warr, J. Loy, and R. Bravo. 1997. Defects in macrophage 
recruitment and host defense in mice lacking the CCR2 chemokine receptor. J 
Exp Med 186:1757-1762. 
216. Shiloh, M.U., J.D. MacMicking, S. Nicholson, J.E. Brause, S. Potter, M. Marino, 
F. Fang, M. Dinauer, and C. Nathan. 1999. Phenotype of mice and macrophages 
deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 
10:29-38. 
217. Serbina, N.V., T.P. Salazar-Mather, C.A. Biron, W.A. Kuziel, and E.G. Pamer. 
2003. TNF/iNOS-producing dendritic cells mediate innate immune defense 
against bacterial infection. Immunity 19:59-70. 
218. Conlan, J.W., and R.J. North. 1994. Neutrophils are essential for early anti-
Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed 
by a granulocyte-depleting monoclonal antibody. J Exp Med 179:259-268. 
219. Rogers, H.W., and E.R. Unanue. 1993. Neutrophils are involved in acute, 
nonspecific resistance to Listeria monocytogenes in mice. Infect Immun 61:5090-
5096. 
220. Czuprynski, C.J., J.F. Brown, N. Maroushek, R.D. Wagner, and H. Steinberg. 
1994. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of 
mice to Listeria monocytogenes infection. J Immunol 152:1836-1846. 
221. Buchmeier, N.A., and R.D. Schreiber. 1985. Requirement of endogenous 
interferon-gamma production for resolution of Listeria monocytogenes infection. 
Proc Natl Acad Sci U S A 82:7404-7408. 
222. Havell, E.A. 1989. Evidence that tumor necrosis factor has an important role in 
antibacterial resistance. J Immunol 143:2894-2899. 
223. Nakane, A., T. Minagawa, and K. Kato. 1988. Endogenous tumor necrosis factor 
(cachectin) is essential to host resistance against Listeria monocytogenes 
infection. Infect Immun 56:2563-2569. 
224. Boehm, U., T. Klamp, M. Groot, and J.C. Howard. 1997. Cellular responses to 
interferon-gamma. Annu Rev Immunol 15:749-795. 
225. Gobin, S.J., A. Peijnenburg, V. Keijsers, and P.J. van den Elsen. 1997. Site alpha 
is crucial for two routes of IFN gamma-induced MHC class I transactivation: the 
ISRE-mediated route and a novel pathway involving CIITA. Immunity 6:601-611. 
226. Pfeffer, K., T. Matsuyama, T.M. Kundig, A. Wakeham, K. Kishihara, A. 
Shahinian, K. Wiegmann, P.S. Ohashi, M. Kronke, and T.W. Mak. 1993. Mice 
deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic 
shock, yet succumb to L. monocytogenes infection. Cell 73:457-467. 
 37 
227. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, 
R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the 
tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but 
highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802. 
228. Finelli, A., K.M. Kerksiek, S.E. Allen, N. Marshall, R. Mercado, I. Pilip, D.H. 
Busch, and E.G. Pamer. 1999. MHC class I restricted T cell responses to Listeria 
monocytogenes, an intracellular bacterial pathogen. Immunol Res 19:211-223. 
229. Freitag, N.E., and K.E. Jacobs. 1999. Examination of Listeria monocytogenes 
intracellular gene expression by using the green fluorescent protein of Aequorea 
victoria. Infect Immun 67:1844-1852. 
230. Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, 
S. Vuthoori, K. Ko, F. Zavala, E.G. Pamer, D.R. Littman, and R.A. Lang. 2002. 
In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T 
cells by exogenous cell-associated antigens. Immunity 17:211-220. 
231. Shedlock, D.J., and H. Shen. 2003. Requirement for CD4 T cell help in generating 
functional CD8 T cell memory. Science 300:337-339. 
232. Foulds, K.E., M.J. Rotte, and R.A. Seder. 2006. IL-10 is required for optimal CD8 
T cell memory following Listeria monocytogenes infection. J Immunol 177:2565-
2574. 
233. Badovinac, V.P., B.B. Porter, and J.T. Harty. 2004. CD8+ T cell contraction is 
controlled by early inflammation. Nat Immunol 5:809-817. 
234. Kursar, M., K. Bonhagen, A. Kohler, T. Kamradt, S.H. Kaufmann, and H.W. 
Mittrucker. 2002. Organ-specific CD4+ T cell response during Listeria 
monocytogenes infection. J Immunol 168:6382-6387. 
235. Messingham, K.A., V.P. Badovinac, A. Jabbari, and J.T. Harty. 2007. A role for 
IFN-gamma from antigen-specific CD8+ T cells in protective immunity to 
Listeria monocytogenes. J Immunol 179:2457-2466. 
236. Portnoy, D.A., R.D. Schreiber, P. Connelly, and L.G. Tilney. 1989. Gamma 
interferon limits access of Listeria monocytogenes to the macrophage cytoplasm. 
J Exp Med 170:2141-2146. 
237. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. 
Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major 
mechanisms of T cell-mediated cytotoxicity. Science 265:528-530. 
238. Berke, G. 1995. The CTL's kiss of death. Cell 81:9-12. 
239. Froelich, C.J., V.M. Dixit, and X. Yang. 1998. Lymphocyte granule-mediated 
apoptosis: matters of viral mimicry and deadly proteases. Immunol Today 19:30-
36. 
240. San Mateo, L.R., M.M. Chua, S.R. Weiss, and H. Shen. 2002. Perforin-mediated 
CTL cytolysis counteracts direct cell-cell spread of Listeria monocytogenes. J 
Immunol 169:5202-5208. 
241. White, D.W., A. MacNeil, D.H. Busch, I.M. Pilip, E.G. Pamer, and J.T. Harty. 
1999. Perforin-deficient CD8+ T cells: in vivo priming and antigen-specific 
immunity against Listeria monocytogenes. J Immunol 162:980-988. 
242. Jensen, E.R., A.A. Glass, W.R. Clark, E.J. Wing, J.F. Miller, and S.H. Gregory. 
1998. Fas (CD95)-dependent cell-mediated immunity to Listeria monocytogenes. 
Infect Immun 66:4143-4150. 
 38 
243. Sun, J.C., and M.J. Bevan. 2003. Defective CD8 T cell memory following acute 
infection without CD4 T cell help. Science 300:339-342. 
244. Shedlock, D.J., J.K. Whitmire, J. Tan, A.S. MacDonald, R. Ahmed, and H. Shen. 
2003. Role of CD4 T cell help and costimulation in CD8 T cell responses during 
Listeria monocytogenes infection. J Immunol 170:2053-2063. 
245. Montfort, M.J., H.G. Bouwer, C.R. Wagner, and D.J. Hinrichs. 2004. The 
development of functional CD8 T cell memory after Listeria monocytogenes 






Development of innate CD4 T cells expressing promyelocytic leukemia zinc finger 
protein is regulated by the strength of TCR signaling 
 
2.1 Abstract 
 Studies have shown that CD4 T cells can be selected by MHC class II-expressing 
thymocytes in addition to TEC in experimental mouse models. This observation offers an 
explanation for CD4 T cell generation by MHC class II-expressing hematopoietic cells in 
humans. Here, we report that TCR signaling regulates the frequency of thymocyte-selected 
CD4 (T-CD4) T cells. T-CD4 T cell development was enhanced when TCR signaling 
strength was weakened due to ITK deficiency, whereas the same deficiency compromised E-
CD4 T cell selection by TEC. The frequency of T-CD4 T cells was decreased when Ras 
activity was augmented by eliminating the Ras deactivating enzyme RASA1. Furthermore, 
T-CD4, but not E-CD4 T cells, expressed the transcription factor promyelocytic leukaemia 
zinc finger (PLZF) protein that is known to be essential for iNKT cell development. 
Furthermore, the CD4 T cells that developed in ITK deficient mice, in which TCR signaling 
was decreased, also expressed PLZF. These findings suggest that the TCR signaling quality 
required for T-CD4 development is different from that required for E-CD4 T cell 
development and is associated with PLZF expression.   
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2.2 Introduction  
 CD4 T cells are developed by the interaction of T cell receptors (TCRs) with their 
ligand major histocompatibility complex (MHC) class II molecules, and they play a key role 
during an adaptive immune response (1-4). The fate of T cells during their development is 
largely determined by the magnitude of TCR signaling, and it is known that a narrow 
window of TCR signaling strength is required for the survival of thymocytes (5-9). Upon 
TCR ligation, a series of protein tyrosine kinases are recruited to the cytoplasmic domains of 
the TCR complex (10-12), where they are activated by phosphorylation and in turn activate 
components of distinct downstream signaling pathways. This cascade of signaling events 
results in the activation of transcription factors for new gene products that are required for 
thymocyte development (13). Particularly, signaling pathways mediated by changes in 
intracellular calcium flux, the NF-(B pathway, and the Ras- MAPK/ERK1/2 cascade are 
known to regulate positive selection of thymocytes (13).  
 
 On the level of proximal TCR signaling, the IL-2 inducible T cell kinase (ITK) plays a 
vital role for thymocyte positive selection (5, 14, 15). Activated by Lck, ITK activates 
phospholipase C-#1, leading to calcium mobilization and MAPK/ERK activation (16). ITK-/- 
mice display impaired conventional CD4 and CD8 T cell positive selection without altering 
their lineage decisions (17). Interestingly, ITK-/- CD8 T cells exhibit innate cell 
characteristics that differ from conventional CD8 T cells (18, 19). However, the development 
of T-CD4 T cells in ITK-deficient mice has not been characterized.  
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The Ras-MAPK/ERK1/2 cascade is known to be important for thymocyte positive 
selection (13) in that positive but not negative selection of thymocytes expressing the H-Y 
male-specific transgenic TCR is severely compromised by expression of a dominant negative 
form of Ras expressed under the control of the Lck proximal promoter (13, 20, 21). In 
addition, gene disruption of ERK1, one of the Ras downstream kinases, also partially blocked 
positive selection (22). The activity of the small GTPase Ras is modulated by positive and 
negative regulators (13). Ras guanine nucleotide exchange factors (GEFs) promote Ras 
activity by catalyzing the exchange of GDP for GTP (23, 24). One of the GEFs, RasGRP1, 
has been shown to be required to mediate TCR signaling to the Ras-ERK1/2 cascade during 
positive selection (24). RasGRP1 deficiency completely abrogates ERK activation and thus T 
cell development (23, 25). On the other hand, Ras GTPase-activating proteins (RasGAPs) 
facilitate GTP hydrolysis and thereby function to inactivate Ras (25-27). RASA1 (p120-
RasGAP), one of the RasGAPs, is critical for normal Ras activity (28) in various cell 
functions, including cell survival, proliferation, and movement (28, 29). However, the role of 
RASA1 in T cell development has not been characterized (27).  
 
In the mouse thymus, cortical TEC are recognized to be the major cell type mediating 
positive selection of conventional CD4 and CD8 T cells (30-32). However, observations in 
humans argue against TEC being the only cell type capable of supporting positive selection. 
Patients who are not able to produce their own CD4 T cells due to defects in MHC class II 
expression can restore CD4 T cells upon bone marrow transplantation, which strongly 
suggests that hematopoietic cells can provide TCR ligands for CD4 T cell selection (33-35). 
Moreover, human thymocytes are likely to be the TCR ligand providers, considering that 
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they express MHC class II molecules (36) and that they are the major cell population in the 
thymus. In order to test whether thymocytes indeed can mediate CD4 T cell selection using 
mouse models, we constructed a transgenic mouse line to express MHC class II molecules on 
mouse thymocytes by introducing the MHC class II transactivator (CIITA) transgene after a 
mouse CD4 promoter. Using this CIITATg mouse model, we have established that MHC class 
II molecules expressed exclusively on thymocytes can support the development of 
unconventional CD4 T cells (37). To distinguish between CD4 T cells that are dependent on 
either TECs or thymocytes for their selection, we will refer to these cells as E-CD4 and T-
CD4 T cells, respectively.  
 
T-CD4 T cells possess unique properties that are not found in E-CD4 T cells. Unlike 
E-CD4 T cells, they produce both Th1 and Th2 cytokines immediately after TCR stimulation 
by anti-CD3 antibody in vitro and in vivo (38). Moreover, T-CD4 T cells but not E-CD4 T 
cells can express IL-4 under Th1-skewing conditions. In addition, T-CD4 T cells produce IL-
4 in a Stat6-independent manner (38), which is due to preformed IL-4 mRNA in T-CD4 T 
cells (38). The functional differences between T- and E-CD4 T cells have been demonstrated 
further by the observation of a protective role of T-CD4 T cells in an airway inflammation 
model (37) as well as in an EAE model (39). In addition, T- but not E-CD4 T cells require 
the SLAM-SAP signaling pathway for their selection. Interestingly, many of these 
characteristics of T-CD4 T cells are also observed in invariant NKT (iNKT) cells (40). iNKT 
cells are also selected by thymocytes (41, 42) and depend on the SLAM-SAP signaling 
pathway for their development (43). More recently, the promyelocytic leukemia zinc finger 
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(PLZF) protein has been recognized as a lineage marker of iNKT cells that is critical for their 
development (44, 45).  
The differences and similarities among T-CD4, E-CD4, and iNKT cells prompted us 
to investigate the role of the TCR signaling strength in the development and functions of 
these cells. Here we report that the strength of TCR signaling regulates the efficiency of T-
CD4 T cell generation. Weakened TCR signaling achieved by eliminating ITK augmented 
the development of T-CD4 T cells while reducing the generation of E-CD4 T cells. By 
contrast, elevated Ras activity in mice lacking RASA1 resulted in diminished T-CD4 but 
enhanced E-CD4 T cell generation. We also observed that PLZF was not only expressed in 
T-CD4 T cells but also in ITK-/- CD4 T cells selected by bone marrow-derived cells in a non-
CIITATg system. Therefore, thymocytes bearing TCRs that received a certain range of 
signaling qualities undergo selection mediated by hematopoietic cells and develop into 
innate-like CD4 T cells that express PLZF.  
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2.3  Materials and Methods 
Mice 
Mice carrying the human type III CIITA transgene (Tg) were described previously 
(46). Tg mice were bred to carry both the CD45.1 and CD45.2 congenic markers. Non-Tg 
littermates from heterozygous Tg breeding were used as wild type (WT) controls. All mice 
were housed in the animal facility at the University of Michigan Medical School under 
specific pathogen-free (SPF) conditions and used at 6-12 weeks of age. All animal 
experiments were performed under protocols approved by the institutions. 
 
Bone marrow chimeric mice 
For bone marrow (BM) transfer experiments, the recipient mice were lethally 
irradiated with 960 rads 24 hr before receiving BM transfers. Total BM cells were harvested 
from the femurs and tibias of donor mice (2–3 months of age) and depleted of mature T cells, 
B cells, and MHC class II-positive lymphocytes by using a cocktail of antibodies containing 
anti-CD4 (RL172), anti-CD8 (TIB105, TIB210), anti-CD19 (1D3), and anti-MHC class II 
(M5/114) followed by complement-mediated lysis. BM cells from two different types of 
donor mice were mixed at the indicated ratio. Each recipient mouse received 4–6 ) 106 cells 
in 200 µl of 1) PBS via tail vein injection. All BM chimeras were reconstituted for 4-6 
weeks before analysis of T cell development and function.  
 
Flow cytometry 
All antibodies used for flow cytometry were purchased from BD PharMingen (San 
Diego, California). Cells were pre-incubated with the anti-Fc!R mAb 2.4G2 to block 
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nonspecific antibody binding before they were stained with the following FITC-, PE-, 
PerCP5.5-, CyChrome-, APC-, or biotin-conjugated antibodies: TCR$ (H57), CD4 (L3T4), 
CD8 (53-6.7), CD45.1 (A20), CD45.2 (104), CD62L (MEL-14), CD44 (IM7), TCRb (H57-
597), NK1.1 (NK1.1), a-GalCer analog-loaded CD1d-trtramer (from NIH tetramer core 
facility), anti-IL-4 (11B11), and anti-IFN-! (XMG1.2). Events were acquired on a 
FACSCanto (Becton Dickinson) flow cytometer, and the data were analyzed with FlowJo 
software.  
 
CD4 T cell preparation and differentiation 
CD4 cells were purified from single-cell suspensions of splenocytes from chimeric 
mice with anti-mouse CD4 microbeads (Miltenyi Biotec, Auburn, California). CD4 T cells (1 
) 106/ml) were stimulated with 5 µg/ml plate-bound anti-CD3 (145-2C11), 1 µg/ml soluble 
anti-CD28 (37.51), and 50 U of IL-2 (Source: Roche, Indianapolis, Indiana) for 5 days. For 
Th1 differentiation, 3.5 ng/ml of IL-12 and 10 µg/ml of anti-IL-4 (11B11) were added.  
 
Cytokine intracellular staining 
Differentiated Th1 CD4 T cells were stimulated with 50 ng/ml phorbol myristyl 
acetate and 1.5 µM ionomycin (Source: Calbiochem, San Diego, California) for 5 hr. 
Monensin (Source: Sigma, St. Louis, Missouri) at 3 µM was added during the last 3 hr of 
stimulation. Activated Th1 cells were stained with anti-CD45.1, anti-CD45.2 antibodies. 
Cells were then fixed in 4% paraformaldehyde for 30 min at room temperature and 
permeabilized with 0.2% saponin (Source: Sigma), followed by staining with anti-IL4 
(11B11) and anti-IFN-! (XMG1.2) mAbs for flow cytometry. 
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Real time PCR:  
A Lightcycler and SYBR Green Master Mix reagents (Source: Roche) were used for 
quantitative real-time PCR of PLZF. Results were normalized by comparison to PCR 
amplification of the gene encoding HPRT (hypoxanthine guanine phosphoribosyl 
transferase). Primers were as follows: PLZF forward, 5'-
TCTGACAAAGATGGGGATGATCC-3', and reverse, 5'-
CAGTATTCCGTGCAGATGGTACAC-3'; HPRT forward, 5'-




 P values were calculated between groups by a two-tailed student’s t test (Prism 5; 
Graph-Pad Software, San Diego, CA). Differences were considered significant at p < 0.05 by 
the Student's t test (unpaired).  
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2.4 Results  
2.4.1    Enhanced T-CD4 T cell development in the absence of ITK 
Previously, we have shown that, different from E-CD4 T cells, T-CD4 T cell 
generation requires signaling through SLAM receptors (47), which led us to investigate 
whether or not T-CD4 T cell development requires the same TCR signaling quality as E-CD4 
T cells.  
 
ITK has been reported to be important for E-CD4 T cell selection (5, 16). To test 
whether it is similarly required for the generation of T-CD4 T cells, we employed a strategy 
of mixed BM reconstitution. We generated T-CD4 T cells by co-transferring ITK-/- BM cells 
with CIITATg BM cells into lethally irradiated A$-/- hosts (ITK-/- + CIITATg!A$-/-: T-BMT). 
In these BM chimeras, TEC do not express MHC class II molecules. Instead, hematopoietic 
cells including thymocytes originating from CIITATg BM cells express MHC class II. 
Therefore, all CD4 T cells including those originating from ITK-/- BM in the chimeras must 
have undergone selection mediated by CIITATg BM driven cells, most likely thymocytes. 
WT cells can be efficiently selected by CIITATg thymocytes in the mixed BM chimeras (52). 
To generate ITK-/- cells that are E-CD4 T cells, we transferred BM cells from ITK-/- and WT 
mice to WT hosts (ITK-/-+WT ! WT: E-BMT). In these mice, MHC class II expressing TEC 
in the host support ITK-/- E-CD4 T cell development. In all cases, we used CD45 congenic 
markers to distinguish cells from the two donors and the recipient.  
 
When ITK-/- cells were selected by TEC (ITK-/-+WT ! WT), the CD4 single positive 
(CD4 SP) compartment was reduced in comparison to the WT partner cells (Fig 2.1 A, left 
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group). By contrast, the percentage of ITK-/- T-CD4 T cells was greater than that of the 
CIITATg BM driven cells in T-BMTs (Fig 2.1 A, right group), suggesting that the absence of 
ITK is beneficial to the generation of T-CD4 T cells. To get a quantitative evaluation, the 
CD4 T cell selection efficiency was calculated as the ratio of the percentage of CD4 SP to 
that of CD4/CD8 double positive (DP) thymocytes. We then used the ratio of ITK-/- CD4 T 
cells to that of the co-transferred partner cells in the same host to get the selection efficiency. 
A ratio of 1 would indicate the equivalent selection efficiency of CD4 T cell generation from 
the two donor BM cells.  If ITK-/- CD4 T cells are selected more efficiently than the co-
transferred partner cells, the ratio would be greater than 1. By contrast, a ratio less than 1 
indicates poorer selection of ITK-/- cells. ITK-/- E-CD4 T cell selection was reduced (Fig 2.1 
B), which is consistent with the published observations that the loss of ITK substantially 
impairs but does not totally abolishes T cell development (5, 16). Surprisingly, T-CD4 T cell 
selection was significantly enhanced in the absence of ITK (Fig 2.1 B), suggesting T-CD4 T 
cell generation is favored by weak TCR signals.  
 
In the periphery, both T- and E-BMT hosts had reduced numbers of CD4 and CD8 T 
cells from ITK-/- BM compared to their partner cells (Fig 2.1 C), consistent with prior reports 
that ITK deficiency resulted in reduced CD4 T cells in the periphery (14, 16). However, 
when ITK-/- and ITK+/+ cells were compared within the T- and E-BMT group, T-CD4 cells 
were reduced by two fold in ITK-/- cells compared to ITK+/+ cells while this reduction was 
five fold for E-CD4 T cells. In addition, the numbers of T-CD4 T cells in the periphery were 
also higher than the numbers of E-CD4 T cells when ITK was absent (Fig 2.1 D, compare 
first and third panels). Therefore, the status of ITK affected E and T-CD4 T cell selection and 
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cellularity. Our previous work showing that mice containing T-CD4 T cells often have a 
decreased CD8 T cell population in the periphery (37) was confirmed here (Fig 2.1 D).  
 
T-CD4 T cells in the periphery exhibit an effector/memory-like phenotype (37). 
These characteristics were maintained in ITK-/- T-CD4 T cells as shown by high expression 
of CD44 and low expression of CD62L, which suggests that ITK contributes to the selection 
process but not to the phenotype of the resulting cells (Fig 2.1 E).   
  
2.4.2    Requirement of RASA1 for the development of T-CD4 T and iNKT cells 
Enhanced T-CD4 T cell development in the absence of ITK suggests that weakened 
TCR signals may favor the generation of T-CD4 T cells.  If this were the case, increased 
signaling strength would result in reduced T-CD4 T cells. To test this, we utilized a mouse 
model of T cell-conditional RASA1 deficiency, in which the increased Ras activity leads to 
enhanced E-CD4 T cell positive selection (unpublished data by Philip Lapinski and Philip 
King). Using the same mixed BM chimera approach as above, we constructed T- and E-BMT 
mice with RASA1-/- BM cells. RASA1-/- BM cells yielded greater CD4 SP than WT cells in 
the E-BMT group (RASA1-/- + WT ! WT) and the overall selection efficiency was also 
increased in the E-BMT group (Fig 2.2 A, left group and Fig 2.2 B). In the T-BMT group 
(RASA1-/- + CIITATg ! A$-/-), however, the selection efficiency of RASA1-/- CD4 T cells 
was much lower than that of CIITATg CD4 T cells, suggesting that RASA1 deficiency 




In the periphery, CD4 and CD8 T cells did not show significant differences in 
cellularity regardless of RASA1 and the selection pathway (Fig 2.2 C and D). Further, 
similar to ITK-/- T-CD4 T cells, RASA1-/- T-CD4 T cells were CD44hiCD62Llo and therefore 
maintained typical T-CD4 phenotype (Fig 2.2 E).  
 
T-CD4 T cells share many similarities with iNKT cells, as we have previously 
reported (37, 47). Because RASA1 deficiency affected T-CD4 T cells and because its role in 
iNKT cells is unknown, we also examined the role of RASA1 in iNKT cell development.  To 
do this, we constructed RASA1-/-+WT!WT chimeras. iNKT cells identified by CD1d 
tetramers were greatly diminished in RASA1-/- originated T cell populations compared to 
WT populations (Fig 2.2 F). The data thus suggest that RASA1 plays an important role in the 
generation of both T-CD4 T and iNKT cells. 
 
2.4.3    Critical role of RasGRP1 for both T-CD4 T and iNKT cell generation 
Having observed that enhancing Ras activity by RASA1 deficiency increased E-CD4 
T cells but reduced T-CD4 T cells, we investigated whether repressing Ras activity would 
enhance T-CD4 selection.  For this purpose, we used mice deficient in RasGRP1, an 
activator of Ras.  In the absence of RasGRP1, E-CD4 T cell development is greatly reduced 
due to the lack of Ras activation and, as a result, positive selection of E-CD4 T cells is 
severely diminished (13).  
 
RasGRP1-/- E- and T-CD4 T cells were generated by transferring RasGRP1-/- BM 
cells with WT BM to WT hosts and with CIITATg BM to A$-/- hosts, respectively.  As 
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expected, CD4 SP thymocytes in E-BMT hosts were severely diminished (Fig 2.3 A, left 
group). Similarly, we observed the disappearance of T-CD4 T cells lacking RasGRP1 (Fig 
2.3 A, right group). The severe reduction of T-CD4 T cells in the thymus resulted in few 
CD4 T cells in the periphery (Fig 2.3 B). Both groups of chimeras also showed reduced CD8 
T cells in the thymuses and the spleens. Together, RasGRP1 plays an indispensable role in 
both T- and E-CD4 T cell as well as CD8 T cell development. In addition, iNKT cells were 
barely detectable in the thymus and the spleen (Fig 2.3 C).  
 
2.4.4    Effect of ITK and RASA1 on the effector function of T-CD4 T cells 
So far, we have shown that the modulation of TCR signaling affected T-CD4 T cell 
development. We next asked whether CD4 T cells developed under different signaling 
environments would possess the same effector functions or not. T-CD4 T cells are 
functionally distinct from E-CD4 T cells in many aspects (37, 38). Most notably, T-CD4 T 
cells produce IL-4 in addition to IFN-! under conditions that favor Th1 differentiation (38). 
Therefore, to ascertain the role ITK and RASA1 in cytokine production, CD4 T cells from 
the spleens of the ITK-/- or RASA1-/- BM chimeras were enriched and differentiated into Th1 
cells followed by intracellular staining of IFN-! and IL-4. The number of RasGRP1-/- CD4 T 
cells was too low to do the functional assessment. 
 
When ITK-/- and WT CD4 T cells were selected by epithelial cells, both ITK-/- and 
WT CD4 T cells produced IFN-! but not IL-4, which is the typical profile of Th1 cells (Fig 
2.4 A, left group). However, we observed that the IFN-! expressing cell population was 
substantially lower when ITK was absent, suggesting a role for ITK in IFN-! expression (Fig 
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2.4 B). In contrast to E-CD4 T cells, ITK-/- and WT T-CD4 T cells expressed IL-4 in addition 
to IFN-! even though they were Th1 differentiated cells (Fig 2.4 A, right group and B). 
Therefore, ITK seems to be less critical for the effector function of T-CD4 T cells. 
 
 We next examined IFN-! and IL-4 expression in Th1 differentiated cells with or 
without RASA1. As shown in Figure 2.4 C, RASA1-/- and WT E-CD4 T cells showed a 
comparable IFN-!-expressing population, and the proportions of IL-4-expressing cells were 
insignificant. Therefore it seems that RASA1 is not involved in Th1 differentiation of E-CD4 
T cells. However, when RASA1-/- cells developed into T-CD4 T cells, they expressed IL-4 
together with IFN-! just as RASA1+/+ T-CD4 T cells did (Fig 2.4 C and D). We also 
observed that RASA1-/- cells tend to have more IL-4+ cells at the expense of IFN-! cells, 
although the difference was not statistically significant. Nevertheless, the key feature of T-
CD4 T cells to produce both Th1 and Th2 cytokines after Th1 differentiation was not altered 
by RASA1 deficiency.  
 
2.4.5    Selection of ITK-/- CD4 T cells by hematopoietic cells  
Data presented above were generated by using a murine model in which thymocytes 
express MHC class II. Based on the fact that ITK-/- + WT!WT chimeras were not able to 
generate ITK-/- CD4 T cells efficiently as ITK-/- + CIITATg!A$-/- chimeras, one might 
conclude that thymocytes but not other hematopoietic cells are capable of mediating 
thymocyte selection. To address whether thymocyte-expressed TCR ligands are indeed 
required for T-CD4 T cell selection, we performed BM transfer experiments using ITK-/- BM 
cells into WT or mice lacking both MHC class I and II. In these hosts, T cell development 
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has to be mediated by hematopoietic cells from the donor cell origin, and importantly the 
donor thymocytes do not express MHC class II. Figure 2.5 A showed that ITK-/- cells 
developed poorly in WT mice compared to that of WT!WT. However, when MHC 
molecules were absent from host TEC, ITK-/- BM cells did better than WT BM cells in 
developing into CD4 as well as into CD8 SP cells. Therefore, the data suggested that MHC 
class II expressing hematopoietic cells can support CD4 T cell development and that the 
frequency of the selected cells increases when ITK is absent.  
 
2.4.6    PLZF expression in hematopoietic cell-selected CD4 T cells  
Recently, PLZF has been recognized as an essential transcription factor for iNKT cell 
development (44, 45). PLZF is expressed in both human and mouse iNKT cells but not in E-
CD4 T cells. However, a recent report showed that human T-CD4 T cells also express PLZF 
(48). In agreement with this study, we observed a distinct PLZF+ CD4 T cell population in 
CIITATg mice that are CD1d-tetramer negative and thus not iNKT cells (Fig 2.5 B). 
Consistent with our previous study, iNKT cells were reduced in CIITATg mice (49). In 
CIITATg mice, CD4 T cells can be developed by TEC as well as by thymocytes because both 
cell types express MHC class II. Therefore, it is likely that PLZF expressing and non-
expressing CD4 T cells are selected by thymocytes and TEC, respectively. If so, we 
hypothesized that forcing all CD4 T cells to undergo selection exclusively by thymocytes 
could enrich PLZF-expressing cells in CD4 T cell compartment. To test this, we constructed 
chimeras to generate T- and E-CD4 T cells and examined CD4 SP cells in the thymus. 
Indeed, PLZF+ CD4 T cells were greatly induced in CD4 SP population from T-BMT mice 
(Fig 2.5 C) although PLZF was not expressed in all CD4 SP cells in T-BMT mice. As 
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expected, neither E-CD4 T cells nor CD8 T cells expressed appreciable levels of PLZF. 
Additionally, in line with T-CD4 T cells, CD4 T cells from ITK-/- mice but not those from 
WT mice expressed a high level of PLZF mRNA (Fig 2.5 D). We also found that the 
majority of PLZF+ CD4 SP cells lost MHC class II (Fig 2.5 E). The CIITA transgene and 
thus the MHC class II expression was down-regulated when CIITATg CD4 T cells were 
activated by CD3 stimulation (data not shown). Therefore, the PLZF+ CD4 SP cells have 
undergone more TCR stimulation than the PLZF- cells.  
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Figure 2.1 ITK deficiency enhances T-CD4 T cell generation.  
(A) ITK-/- BM (CD45.2) and wild type (WT) BM (CD45.1 and CD45.2) were mixed and 
co-transferred into B6.SJL hosts (CD45.1) (ITK-/- + WT ! WT) at the ratio of 3:1 to 
generate E-CD4 T cells. To produce T-CD4 T cells, ITK-/- BM (CD45.2) and CIITATg 
BM (CD45.1 and CD45.2) were introduced to A$-/- hosts (CD45.1) (ITK-/- + CIITATg ! 
A$-/-) at the ratio of 3:1. Mice were sacrificed 5-6 weeks after the BM transplantation. 
Total thymocytes were used to analyze T cell subsets. The numbers in the dot plots 
indicate the percentages of gated cells derived from each BM type using the CD45 allele. 
Data are representative of four mice in each group. (B) CD4 T cell selection efficiency 
was expressed as a ratio using the formula (% CD4 SP / % DP of ITK-/-) / (% CD4 SP / % 
DP of the partner) as described in the text. The dotted line indicates the ratio of 1. (C and 
D) Splenic cells from the same chimeras in (A) were used to assess peripheral CD4 and 
CD8 T cell compartments. Representative staining data are shown in (C) and the bar 
graphs in (D) are mean±SE from 4 mice in each group. (E) CD44 and CD62L expression 
of splenic CD4 T cells in (C) was analyzed. ITK-/- BM was from Dr. Pam Schwartzberg’s 
lab. 
 






Figure 2.2 T- and E-CD4 T cell development in the absence of RASA1  
(A) BM chimeras were constructed as indicated using the ratio of 1:1 of BM cells. Mice 
were sacrificed 5-6 weeks after transplantation and total thymocytes were analyzed. The 
numbers in the dot plots indicate the percentages of gated cells derived from each BM 
types (N=6). (B) CD4 selection efficiency of RASA-/- cells relative to the co-transferred 
partner cells were calculated as in Figure 2.1. The dotted line indicates the ratio=1. (C and 
D) Splenic cells from the same chimeras in (A) were used to assess peripheral CD4 and 
CD8 T cells. Representative staining data are shown in (C) and the bar graphs in (D) are 
mean±SD (N=6). (E) CD44 and CD62L expression of splenic CD4 T cells in (C). (F) 
iNKT cell development was severely reduced in the absence of RASA1. Numbers indicate 
the percentages of iNKT cells among total thymocytes or splenocytes. RASA1-/- BM was 
from Dr. Philip King’s lab. 
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Figure 2.3 RasGRP1 is essential for both T- and E-CD4 T cell generation 
(A) To generate E-CD4 T cells, RasGRP1-/- BM (CD45.2) and WT BM (CD45.1 and 
CD45.2) were mixed and co-transferred into B6.SJL hosts (CD45.1) (RasGRP1-/- + WT 
! WT) at the ratio of 3:1. RasGRP1-/- bone marrow (CD45.2) and CIITATg BM (CD45.1 
and CD45.2) were mixed and co-transferred into A$-/- hosts (CD45.1) (RasGRP1-/- + 
CIITATg ! A$-/-) at the ratio of 3:1 to generate T-CD4 T cells. Mice were sacrificed 5-6 
weeks after transplantation. Total thymocytes (A) and splenocytes (B) from indicated 
mice were analyzed to assess CD4 and CD8 T cell compartments. The numbers in the dot 
plots indicate the percentages of gated cells derived from each BM types. (C) iNKT cell 
development was severely reduced in the absence of RasGRP1. Numbers indicate the 
percentages of iNKT cells among total thymocytes or splenocytes. Data are representative 
of five mice. RasGRP1-/- BM was from Hung-Sia Teh’s lab. The experiments were done 
by Lingqiao Zhu.  
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Figure 2.4 Role of ITK and RASA1 in the cytokine expression  
Splenic CD4 T cells from indicated mice were enriched and cultured under the Th1 
differentiating conditions as described in the Materials and Methods followed by 
intracellular staining of IFN-! and IL-4. (A, C) Representative staining of ITK-/- (A) or 
RASA1-/- (C) BM chimeras. The numbers in the dot plots indicate the percentages of 
gated cells derived from each BM type. (B, D) Summary of the percentage of IFN!- or 
IL-4-producing cells in the experiments of (A) and (C), respectively. Shown are 
mean±SD of 3 and 4 mice of ITK and RASA1, respectively.  
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Figure 2.5 Expression and role of PLZF in hematopoietic cell-selected CD4 T cells.  
(A) WT or ITK-/- BM cells were transferred to B6 or mice lacking both MHC class I and 
II. Representative CD4 and CD8 profiles of total thymocytes were shown. The numbers in 
the dot plots indicate the percentages of donor cells. (B) Representative CD4 and CD8 
staining of total thymocytes from WT and CIITATg mice (top panels) and PLZF staining 
of CD4 SP gated population shown above (bottom panels). (C) T- and E-CD4 T cells were 
generated using WT!WT and Tg!A!-/- mice, respectively. Total thymocytes were 
stained to assess PLZF expression. Shown are CD1d-tetramer negative CD4 and CD8 SP 
cells. (D) CD4 and CD8 T cells from WT and ITK-/- mice were sorted and used to prepare 
RNA and the level of PLZF mRNA was measured using quantitative RT-PCR. (E) The 
mice used in (B) were examined to assess PLZF and IAb expression in CD4 SP 




2.5 Discussion  
In the current study we showed that the same TCR signaling modulation affected 
T- and E-CD4 development oppositely. Decreased TCR signaling due to ITK deficiency 
reduced E-CD4 T cell selection efficiency as expected but enhanced that of T-CD4 T 
cells. On the contrary, increased Ras activity in the RASA1-/- model resulted in more E-
CD4 but less T-CD4 T cell generation (Table 2.1). Based on these observations, we 
propose that T-CD4 T cell selection prefer weak TCR signals compared to E-CD4 T cell 
selection. Since thymocyte survival requires a certain amount of intracellular signaling, it 
is likely that additional signaling pathways are involved to compensate the differences in 
TCR signaling properties. One good candidate is the SLAM-SAP pathway, which is 
essential for T-CD4 but not required for E-CD4 T cell generation.  
Table 2.1 Summary of TCR signaling modulations on T- and E-CD4 selection 
  TCR signaling E-CD4 selection T-CD4 selection 
ITK-/- " " # 
RASA1-/- # # " 
RasGRP1-/- "" N/A N/A 
 
Contrary to RASA1 deficiency that compromised both iNKT and T-CD4 T cell 
development (Fig 2.2), ITK deficiency that enhanced T-CD4 T cell generation (Fig 2.1) 
resulted in decreased iNKT cell generation (50). One potential reason for the different 
effect of ITK deficiency on iNKT and T-CD4 development lies in the diversity of the 
TCR repertoire. iNKT cells are known to have a limited TCR repertoire and thus the 
range of TCR signaling strength that allows for their survival would also be very narrow. 
In contrast, T-CD4 T cells with a diverse TCR repertoire respond to a wider signaling 
window and thus survive better. Alternatively, ITK may play a crucial role for the 
maturation of iNKT cells, and yet may not be required for T-CD4 T cell development. 
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We have demonstrated similar requirements with T-bet and IL-15R#, both of which are 
important for iNKT cell but not for T-CD4 T cell development. Therefore, the 
developmental processes of T-CD4 T cells and iNKT cells are distinct from each other 
despite certain similarities. 
 
Both ITK-/- and RASA1-/- T-CD4 T cells maintained their potential to express IL-
4 under Th1 differentiation conditions. We suspect that although the selection efficiency 
was affected in the absence of ITK or RASA1 due to the change in signaling quality 
overall, CD4 T cells in the periphery must have received an adequate amount of signaling 
during development in the thymus and thus have survived. Therefore, it is not surprising 
that these cells possess the typical T-CD4 T cell properties. In addition, RASA1-/- T-CD4 
T cells seem to have more IL-4+ cells and fewer IFN-# expressing cells compared to their 
WT partner T-CD4 T cells, indicating that increased Ras activity enhances the potential 
of T-CD4 T cells to express IL-4. This is consistent with a previous report that reduced 
Ras activity results in decreased IL-4 production (51). 
 
PLZF was expressed not only in T-CD4 T cells but also in ITK-/- CD4 T cells. It 
has been reported that ITK deficiency impairs E-CD4 T cell generation but enriches an 
innate-like CD4 T cell population (47). It is likely that the PLZF-expressing sub-
population of CD4 T cells in ITK-/- mice were indeed these innate-like cells. If this were 
the case, PLZF expression during CD4 T cell development correlates well with their 
signaling quality in determining T cell fate. Moreover, PLZF+ CD4 T cells are present in 
humans (48), consistent with the idea that they represent a similar innate-like CD4 T cell 
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population. Together, these observations suggest the presence of a CD4 T cell population 
that has gone through hematopoietic cell-mediated selection in both humans and WT 
mice. Supporting this notion, Tanaka et al. have reported that a fraction of CD4 T cells in 
WT mice possess the memory/effector phenotype and constitutively express IL-4 (52). 
However, the frequency of these cells seems to be very low in WT mice presumably due 
to dominant TEC-mediated selection.  
 
We observed that not all T-CD4 T cells express PLZF in the thymus. A recent 
study also reported the same pattern of PLZF expression in thymocyte-selected CD4 T 
cells in humans (53). Moreover, PLZF+ cells express a higher level of IL-4 than CD4 T 
cells that do not express PLZF (48). A similar observation was made in #$ T cells and it 
is proposed that PLZF+ and PLZF- #$ T cells represent two distinct lineages (53). It is 
plausible, therefore, that T-CD4 T cells are comprised of two sub-populations with 
different characteristics associated with PLZF expression. Perhaps, the TCR repertoires 
are different between the two populations. It is well known that there are two types of 
NKT cells that are CD1d restricted. One population, named iNKT cells, shows the 
limited TCR usage, and the other has a more diverse repertoire. It is not clear what 
regulates the generation of these two populations. However, as developmental 
requirements of the two are not identical, it is likely that the difference in signaling 
during development could account for the different characteristics of the two. The other 
possibility is that, upon positive selection, T-CD4 T cells receive an additional signal to 
up-regulate PLZF expression. This suggests a two-step process of T-CD4 T cell 
generation in the thymus. The signal given at the first step is primarily via the TCR-MHC 
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interaction and results in thymocyte survival, while a subsequent and unidentified second 
signal induces PLZF expression.  
 
Together, the current study suggests that thymocytes with TCRs that deliver weak 
signals are directed to get selected by hematopoietic cells, express PLZF, and become 
effector cells immediately after selection. It is likely that human CD4 T cells are 
generated by similar mechanisms, and further studies on human T-CD4 T cells are 
warranted to gain a better understanding of the development and function of these innate 
CD4 T cells in humans. 
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Conventional CD4 T cells developed by thymic epithelial cells (E-CD4 T cells) 
play critical roles in adaptive immunity by regulating immune responses and the 
development of immune memory. Previously, we discovered a new CD4 T cell 
population that is selected by MHC class II expressing thymocytes and named T-CD4 T 
cells. In addition to different developmental requirements, T-CD4 T cells exhibit distinct 
effector functions by producing cytokines immediately after stimulation. Here, we report 
the suppressive role of T-CD4 T cells on CD8 T cell responses during bacteria infections. 
Using a mouse model of Listeria monocytogenes infection, we observed that T-CD4 T 
cells control immune responses during the adaptive, but not the innate phase. In the 
presence of T-CD4 T cells, Listeria-specific CD8 T cells decreased in frequency as well 
as in killing efficiency. Furthermore, T-CD4 T cells suppressed the development of CD8 
T cell-mediated immune memory, leading to high bacterial burden upon re-infection. In 
addition, this suppression function was dependent on cell-cell contact. Thus, our study 




Conventionally, CD4 T cells modulate adaptive immunity by differentiating into 
helper cell subsets and producing cytokines according to the environmental signals. For 
example, Th1 cells produce the pro-inflammatory Th1 cytokine IFN-#, and facilitate CD8 
T cell-mediated cellular immunity against intracellular pathogens, whereas Th2 cells 
produce cytokines IL-4, IL-5 and IL-13, which are critical for B cell differentiation and 
antibody-mediated humoral immunity. Moreover, CD4 T cells are required for the 
development of CD8 T cell and B cell immune memory in various infection models (1-
6).  
 
It is well established that conventional murine CD4 T cells are selected on thymic 
epithelial cells (TEC) that express TCR ligands, the peptide-MHC class II complexes (7). 
However, studies have indicated a non-conventional way to generate CD4 T cells in 
humans, which is independent of TEC-expressed MHC class II (8-10). The alternative 
cell types supporting CD4 T cell development seem to be hematopoietic cells, 
particularly thymocytes (11-13). Using mouse models, we have demonstrated that indeed 
MHC class II-expressing thymocytes successfully mediate CD4 T cell selection 
independent of TEC-expressed MHC class II (14). CD4 T cells selected by MHC class II 
on thymocytes are called thymocyte-selected CD4 (T-CD4) T cells, as distinguished from 
conventional TEC-selected CD4 (E-CD4) T cells. Unlike E-CD4 T cells, T-CD4 T cells 
secrete IL-4 even after having undergone Th1 differentiation (15). Moreover, T-CD4 T 
cells rapidly produce Th1 and Th2 cytokines upon TCR stimulation both in vitro and in 
vivo (14, 15). These characteristics suggest that T-CD4 T cells resemble invariant natural 
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killer T (iNKT) cells in their innate-like functional characteristics (16-20), although these 
two populations differ in TCR ligands and NK cell marker expression. In addition, mice 
possessing T-CD4 T cells are protected from allergen-induced airway inflammation (21) 
and experimental autoimmune encephalomyelitis (EAE) (22), which are clear 
demonstrations of T-CD4 T cell functional characteristics distinct from those of E-CD4 T 
cells. However, the role of T-CD4 T cells in immune responses against bacterial 
infections has not been addressed.  
 
Listeria monocytogenes is a facultative intracellular pathogen. The pathogenesis 
and the immune responses triggered by the infection have been widely studied in mouse 
models (23). Upon infection, L. monocytogenes are taken up primarily by phagocytes and 
killed within phagosomes. However, they can escape from phagosomes into the cytosol 
through listeriolysin O (LLO)-dependent mechanisms (24), and thence are processed and 
presented through the MHC class I pathway, inducing robust cellular immunity (25-28). 
L. monocytogenes-specific CD4 and CD8 T cells are major mediators of primary as well 
as memory immune responses. They exhibit similar responding kinetics with regards to 
activation, expansion and contraction (27), and produce large amounts of the Th1 
cytokine IFN-#, which is critical for the anti-microbial activity of macrophages (29-31) 
and the up-regulation of MHC expression on antigen presenting cells (APCs) (32-34). In 
addition, CD8 T cells (also called cytotoxic T lymphocytes, CTLs) can directly kill 
infected cells, which is an important mechanism of bacterial clearance (35-38).  
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Immunological memory protects host organisms by clearing recurrent infections 
with enhanced rapidity and effectiveness. Studies have reported the essential role of E-
CD4 T cells in the establishment and development of memory immunity against L. 
monocytogenes infection (1, 2, 39, 40). When E-CD4 T cells are present, mice are able to 
mount a primary immune response resulting in the generation of L. monocytogenes-
specific effector CD8 T cells and the elimination of bacteria. Meanwhile, memory CD8 T 
cells are generated, which effectively eliminate the bacteria upon re-infections. In the 
absence of E-CD4 T cells, CD8 T cells suffer from a defective memory immune response 
upon re-infection, although during a primary L. monocytogenes infection, the mice clear 
bacteria with a similar efficiency to when E-CD4 T cells are present (1, 2, 39-41). This 
suggests that E-CD4 T cells play a critical role in establishing immunological memory to 
L. monocytogenes infection. Here we report that, in contrast to E-CD4 T cells, T-CD4 T 
cells resulted in suppressed CTL responses against L. monocytogenes during both 
primary and secondary infection, as evidenced by reduced frequency of L. 
monocytogenes-specific CD8 T cells and high bacterial burden. Moreover, this 
suppressive function of T-CD4 T cells is cell-contact dependent and is distinct from that 
of Foxp3-expressing regulatory T cells. Thus, our work has identified a novel regulatory 
role of T-CD4 T cells in the immune response to infections by bacterial pathogens.  
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3.3 Materials and Methods 
Mice  
CIITATg (Tg) and WT littermates were bred and kept under specific pathogen–
free conditions in the animal facility at the University of Michigan Medical School. 
C57BL/6 mice at 7-8 wk of age were purchased from Jackson or NCI. CD45.1+ B6 mice 
(B6.SJL-Ptprca/BoyAiTac) and CD45.1+ A!-/- mice (B6.SJL-Ptprca/BoyAiTac H2-
Ab1tm1Gru) (7-8 wk of age) were purchased from Taconic. All mice used were 6-12 wk of 
age. All experimental procedures and protocols were approved by the University 
Committee on Use and Care of Animals. 
 
Bacteria strain 
The recombinant strain of L. monocytogenes expressing a secreted form of 
ovalbumin (rLM-OVA) was previously described (42).  rLM-OVA was grown in brain 
heart infusion broth (Difco) to mid-exponential phase prior to injection i.v. into mice. 
5)105 rLM-OVA are equivalent to 0.5 LD50 for infection (43).  
 
T- and E-CD4 T cell generation  
T- and E-CD4 T cells were generated by transferring BM cells from CIITATg (Tg) 
or WT to lethally irradiated A!-/- (MHC class II-deficient) or WT hosts, respectively. 
Eight weeks after the transfer, the hosts were sacrificed and CD4 T cells were enriched 




Adoptive transfer model  
The recipients were sub-lethally irradiated (500 rad). Three days later, each of 
them received ~3x107 CD4 T cell-depleted splenocytes from WT mice mixed with 107 E-
CD4 or T-CD4 T cells obtained from BM chimeric mice using anti-mouse CD4 
microbeads (Miltenyi Biotec). The mice were rested overnight and then infected with 
rLM-OVA as indicated in each experiment via the i.v. route.  
 
Quantification of bacterial load 
Livers were removed and put into 14-ml tubes containing 10 ml PBS with 0.2% 
NP40. The tissues were homogenized by using a homogenizer (The Lab Depot, Inc.) at 
maximum speed for 30 seconds. Tissue homogenates were subjected to 10-fold serial 
dilutions and then plated onto Luria broth agar plates.  The number of colonies formed 
were counted after 24 hour of incubation at 37°C.   
 
Stimulation of rLM-OVA-specific T cell population ex vivo and cytokine intracellular 
staining 
Splenocytes from infected and naïve mice were stimulated with SIINFEKL 
peptide (1ug/ml, Biomatik Corporation) to detect rLM-OVA-specific CD8 T cells or with 
LLO (listeriolysin O) 190-201 to detect rLM-OVA-specific CD4 T cells. Splenocytes 
were incubated with 1ug/ml peptide for five hours, and monensin was added before the 
last three hours to stop the secretion of the synthesized cytokines. After five hours, cells 
were washed and stained with anti-CD4 and anti-CD8 antibody. Next, cells were fixed in 
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2% paraformaldehyde for 30 min at room temperature, permeabilized with 0.2% saponin 
(Sigma), and stained with anti-IFN-! (XMG1.2) for flow cytometry. 
 
Flow cytometry 
Antibodies specific for CD4 (GK1.5), CD8 (53-6.7), CD45.1 (A20), CD45.2 
(104), TCR! (H57-597), NK1.1 (PK136), Ly-6G (Gr-1), CD11c (HL3), CD11b (M1/70), 
F4/80 (6F2), I-Ab (AF6-120.1), H-2Kb (AF6-88.5) were from PharMingen, BD 
Bioscience. The antibody against Foxp3 (FJK-16s; eBioscience) was used according to 
the staining protocol provided by the company. Samples were analyzed using a FACS 
Canto flow cytometer (Becton Dickinson). Data were analyzed using FlowJo software 
(Tree Star).  
 
In vivo CTL assay 
Splenocytes from naive mice, depleted of red blood cells, were split into two 
portions. One was labeled with a high concentration of CFSE (5.0 nM, 2 x 107 cells/ml) 
and pulsed with OVA 257-263 peptides as the target population. The other was labeled 
with a low concentration of CFSE (0.5 nM, 2 x 107 cells/ml) without peptides as a 
control.  Cells were washed and then the two populations were mixed at 1:1 ratio (4-5 x 
106 cells each). Cells were injected into rLM-OVA infected or PBS-treated mice. Mice 
were sacrificed at indicated time points, and single-cell suspensions of spleens were 
analyzed by flow cytometry. The killing efficiency was calculated as follows: 100 - ([(% 
peptide pulsed in infected/% unpulsed in infected)/(% peptide pulsed in uninfected/% 
unpulsed in uninfected)] x 100). 
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CFSE proliferation assay 
Cells were purified and incubated with CFSE (5 nM) at 37°C for 10 minutes, 
washed three times, and then cultured for 3-4 days under indicated conditions. Cell 
proliferation was measured by CFSE dilution using flow cytometry.  
 
Real-time RT-PCR 
 Total RNA of the splenocytes from infected and control mice were extracted 
using TRIzol (Invitrogen). The PCR reactions were performed and analyzed using the 
iCycleriQTM (BioRad). Conditions: 95°C for 5min, followed by 40 cycles of 95°C for 30 
sec, 55°C for 30 sec, and 72°C for 40 sec. Primers: GAPDH Forward (F): 
ctccactcacggcaaattca, Reverse (R): cgctcctggaagatggtgat. IL-1 F: 
caaccaacaagtgatattctccatg, R: gatccacactctccagctgca. IL-10 F: ggttgccaagccttatcgga, R: 
acctgctccactgccttgct. IFN-! F: tcaagtggcatagatgtggaagaa, R: tggctctgcaggattttcatg. TNF-# 
F: ccccaaagggatgagaagtt, R: cacttggtggtttgctacga  
 
Statistical analysis 
The statistical analysis was done using Prism software. A two-tailed t-test was 
used for statistical analysis. p values of *0.05 were considered significant, and p values > 




3.4.1    CTL immune responses were decreased in mice with T-CD4 T cells  
To ascertain the role of T-CD4 T cells during bacterial infection, we employed a 
well-established murine model of L. monocytogenes infection, and compared the immune 
responses between two groups of mice: wild type (WT) and CIITATg (Tg) mice. Tg mice 
express MHC class II on thymocytes in addition to TEC, and thus thymocytes can be 
selected by both cell types to become T- or E-CD4 T cells. As a consequence, Tg mice 
have both T- and E-CD4 T cells. By contrast, WT mice have only E-CD4 T cells because 
they express MHC class II only on TEC in the thymus. Therefore, the differences in the 
immune responses between WT and Tg mice is likely caused by the presence of T-CD4 T 
cells in addition to E-CD4 T cells in Tg mice.  
 
To facilitate the detection of the dominant Listeria-specific cell populations, we 
chose a recombinant strain of L. monocytogenes expressing a secreted form of chicken 
ovalbumin (rLM-OVA). The primary immune response was analyzed on day 7 after i.v. 
infection. The host bacterial loads in the spleen and the liver were under the limit of 
detection at the time of analysis, and the numbers of splenic CD4 and CD8 T cells were 
comparable between Tg and WT groups (Fig 3.1 A). To measure the pathogen-specific T 
cell response, CD4 and CD8 splenocytes were stimulated separately ex vivo with rLM-
OVA-specific peptides for five hours. T cells recognizing the peptide responded by 
producing IFN-#, which was detected by intracellular staining. The two groups of mice 
exhibited different antigen-specific T cell responses; Tg mice decreased in rLM-OVA-
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specific CD8 T cells (Fig 3.1 B) but increased in the percentage and the number of rLM-
OVA-specific CD4 T cells in comparison with WT mice (Fig 3.1 C). 
 
 Another important indicator of the efficiency of the response is the potency of 
CTL cytotoxicity (35-38). Therefore, an in vivo killing assay was employed to measure L. 
monocytogenes-specific killing efficiency (3, 44). In brief, total splenocytes were either 
labeled with a high concentration of CFSE and pulsed with OVA peptides as a target 
population, or labeled with a low concentration of CFSE without peptides as a control.  
These two populations were mixed 1:1 and injected into infected Tg and WT mice and 
into uninfected naïve mice as controls. While the ratio of the two populations injected 
would stay steady in naïve mice, the CFSEhi cells would decrease in infected mice as they 
were recognized and killed by rLM-OVA-specific CTLs. Three hours after the injection, 
mice were sacrificed, and the composition of the injected cells in the spleens were 
analyzed by flow cytometry. As expected, the ratio of CFSEhi to CFSElo populations 
stayed around 1:1 in naïve mice but decreased in infected mice (Fig 3.1 D). However, the 
difference in the killing efficiency between the two infected groups was not significant.  
3.4.2    Memory immune responses against L. monocytogenes were impaired in the 
presence of T-CD4 T cells 
It has been demonstrated that E-CD4 T cells play a critical role in the 
establishment of optimum CTL immune memory against L. monocytogenes (1, 2, 39, 40). 
To study the role of T-CD4 T cells in the course of CTL memory generation, Tg and WT 
mice were infected with a low dose of rLM-OVA, rested for one month, and re-infected 
with a high dose of rLM-OVA. Three days after the second infection, the numbers of 
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total CD4 and CD8 splenocytes were comparable between Tg and WT mice (Fig 3.2 A). 
However, Tg mice had decreased rLM-OVA-specific CD8 T cells (Fig 3.2 B), although 
rLM-OVA-specific CD4 T cells were comparable between the two groups (Fig 3.2 C). 
To test the effector function of CTLs in vivo, we measured the capability of mice to clear 
bacteria by counting the number of live bacteria harvested from the liver. We observed 
higher bacterial burdens in Tg than in WT mice (Fig 3.2 D), further suggesting the 
immune capacities of Tg mice were less potent than that of WT mice.  
3.4.3    T-CD4 T cells were responsible for the reduced anti-Listerial response 
The reduced efficiency of anti-Listerial responses in Tg mice led us to 
hypothesize that T-CD4 T cells function to diminish anti-Listerial immunity. However, it 
was unclear whether the difference was due to T-CD4 T cell function directly or 
secondary to some other unknown differences between Tg and WT mice. In fact, we 
previously demonstrated that iNKT cells are decreased in Tg mice (45). Therefore, to 
eliminate the possibility that other immune cells influence the outcome of infection, we 
established an adoptive transfer mouse model (Fig 3.3 A). T-BMT (Tg !A!-/-) and E-
BMT (WT !WT) mice were constructed to obtain T- and E-CD4 T cells, respectively. 
These chimeric mice were sacrificed eight weeks after BM transplantation to prepare 
CD4 T cells from splenocytes. Total T- or E-CD4 splenocytes were mixed with CD4 T 
cell-depleted splenocytes from naïve WT mice and adoptively transferred to C57BL/6 
mice that were sub-lethally irradiated three days prior to cell transfer. The transferred 
cells can be distinguished from recipient cells by different CD45 allotype markers. The 
sub-lethal irradiation of hosts eliminates a large portion of host lymphocytes facilitating 
plantation of the incoming cells and also abolishes the immune responsiveness of the 
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remaining host cells (46-48). Thus, the T cell immune responses are primarily attributable 
to the transferred cells. Flow cytometry analysis of E-CD4 and T-CD4 T cells prior to 
transfer showed a similar cell composition between the two (Fig 3.3 B).  
 
Recipient mice were infected with rLM-OVA one day after cell transfer and 
sacrificed 7 days after infection (Fig 3.3 A). The total number of transferred CD8 T cells 
remained unperturbed after seven days (Fig 3.3 C), but the proportion of rLM-OVA-
specific CD8 T cells was significantly lower in T-CD4 hosts than in E-CD4 hosts (Fig 3.3 
D). In contrast, although the total T-CD4 T cell numbers were reduced (Fig 3.3 C), IFN-
#-expressing CD4 T cells were present at comparable levels between the two groups (Fig 
3.3 E). Therefore, rLM-OVA-specific T-CD4 T cell numbers were much less than that of 
E-CD4 T cells. Next, we investigated whether the cytotoxic function of CD8 T cells also 
was affected by T-CD4 T-cells. Consistent with the reduction of IFN-# expressing CD8 T 
cells, the in vivo CTL assay performed as in Fig 3.1 D showed significantly decreased 
CTL cytotoxicity of T-CD4 hosts  (Fig 3.3 F). Thus, we concluded that T-CD4 T cells are 
responsible for suppressive effects on CTL effector function.  
 
3.4.4   T-CD4 T cells suppressed anti-Listerial memory immunity 
The data from adoptive transfer experiments clearly showed the role of CD4 T 
cells on CTLs during primary immune responses. It was anticipated that a poor primary 
CTL response would lead to a deficient memory response. To test this, we prepared cells 
and conditioned the recipient mice as described in Fig 3.3, and then followed this with 
rLM-OVA infection (Fig 3.4 A). We also included an additional group of host mice 
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receiving donor cells that did not contain CD4 T cells. Three groups of mice receiving 
different populations of cells (Fig 3.4 B) were infected, rested for one month, and then 
infected again with a high dose of rLM-OVA. Three days after the secondary infection, 
we found that the number of total splenocytes was lower in mice receiving T-CD4 T cells 
(Fig 3.4 C). Furthermore, the percentages as well as cell numbers of both CD8 and CD4 
T cells specific for rLM-OVA were greatly decreased in T-CD4 hosts (Fig 3.4, D and E), 
indicating a greater deficiency in memory responses than in primary responses. When we 
measured in vivo responses, T-CD4 hosts showed the high median values of the bacterial 
burdens, which were comparable to those of mice that did not receive CD4 T cells (Fig 
3.4 F).  
3.4.5    T-CD4 T cells did not affect the innate response but suppressed CTL 
proliferation 
Next, we sought possible mechanisms for the inhibitory function of T-CD4 T 
cells on CTL responses. We have shown that T-CD4 T cells can produce IL-4 upon 
stimulation in vivo, and also under Th1 differentiating conditions in vitro. Therefore, it is 
possible that T-CD4 T cells produce IL-4 during L. monocytogens infection, which might 
have a negative effect on CTL function not to express IFN-#. However, IL-4 producing 
CD4 T cells were not detected on day seven (Fig 3.5 A). Considering the prompt 
responsiveness of T-CD4 T cells upon anti-CD3 stimulation, we speculated that T-CD4 T 
cells might respond early and alter the course of innate immune responses, which in turn 
might account for the suppressed adaptive immune responses (49, 50). To test this 
hypothesis, we first measured cytokine levels in the spleen from Tg and WT mice on day 
three of the primary infection. Contrary to our prediction, the mRNA expressions of IFN-
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#, TNF-" and IL-1! were comparable between the two groups (Fig 3.5 B). In addition, 
when we examined innate cell populations expressing Gr-1 and F4/80, both Tg and WT 
groups showed increased Gr1+ F4/80+ populations at a comparable level after infection 
(Fig 3.5 C).  
 
Next, we investigated the effect of T-CD4 T cells on CTL proliferation and 
function. CD4 T cell-depleted splenocytes containing mainly CD8 T cells and B cells 
were labeled with CFSE and then stimulated with anti-CD3 antibody in the presence of 
E- or T-CD4 T cells obtained from the same kind of BMT mice in Fig 3.3. Three days 
later, CTL proliferation was measured by CFSE dilution and cytokine production was 
measured by intracellular staining. CTLs co-cultured with T-CD4 T cells underwent less 
proliferation than those cultured with E-CD4 T cells (Fig 3.5 D, left panel). However, 
their IFN-# production was not significantly altered upon re-stimulation by PMA and 
ionomycin (Fig 3.5 D, right group).  
 
To find out whether the suppressive effect of T-CD4 T cells on CTL proliferation 
is mediated by soluble factors or requires cell-to-cell contact, E- or T-CD4 T cells were 
stimulated for two days and the supernatants of the cell culture were collected. CFSE-
labeled WT CTLs were stimulated with the anti-CD3 antibody and cultured with E- or T-
CD4 T cell supernatant for 3-4 days. The CFSE dilution of CTLs was not significantly 
different between the two samples, and thus the supernatants from the T-CD4 T cell 
cultures did not alter CTL proliferation (Fig 3.5 E), indicating that soluble factors 
secreted by T-CD4 T cells were not involved in the suppressive function. The cell contact 
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dependent inhibition prompted us to assess whether T-CD4 T cells could be regulatory T 
cells (Treg). To test this, we examined Foxp3-expressing Treg populations in the E-CD4 
or T-CD4 cells. The percentage of Foxp3+ cells was not significantly different between 
the two (Fig 3.5 F). We have shown previously that the suppressive functionality of Treg 
in T-CD4 T cells was not different from that seen in E-CD4 T cells (15). Therefore, the 


















































Figure 3.1 Reduced anti-Listerial responses in Tg mice during primary infection 
Tg and WT littermates were infected intravenously with rLM-OVA (5 x 104) or PBS. 
Mice were euthanized and analyzed 7 days after infection. (A) Numbers of the total 
splenocytes and of the indicated cell populations are shown. (B, C) Frequencies of IFN-#-
producing rLM-OVA-specific CD8 (B) and CD4 (C) T cells. Total splenocytes were 
stimulated in the presence of rLM-OVA peptides for 5 hours followed by intracellular 
cytokine staining. The values in representative FACS profiles are percentages of the total 
splenocyte population; the graphs on right show the percentage of CD8 (B) and CD4 (C) 
T cells that produced IFN-#. The bars indicate the median value. (D) In vivo killing assay.  
A mixture of cells comprised of the OVA peptide loaded target cells (CFSEhi) and the 
control cells (CFSElo) were injected into recipient mice. Mice were euthanized 3 hours 
after cell transfer. The killing efficiency was calculated as following: 100 - ([(% peptide 
pulsed in infected mice/% unpulsed in infected mice)/(% peptide pulsed in uninfected 


















































Figure 3.2 Poor memory CTL response in Tg mice 
Tg and WT littermates were infected intravenously with 4)103 rLM-OVA and rested for 
one month before a secondary infection with 5)105 rLM-OVA or PBS as a control.  All 
the mice were sacrificed and analyzed 3 days after the secondary infection. (A) Numbers 
represent the total splenocytes and the indicated cell populations. (B, C) Frequencies of 
IFN-#-producing rLM-OVA-specific CD8 (B) and CD4 (C) T cells. Experiments and 
data analyses were done as described in Fig 3.1 B and C. (D) Numbers of viable bacteria 
from liver homogenates are depicted. The bars indicate median values. The colony 






























Figure 3.3 Effector CD8 T cell generation is compromised in the presence of T-CD4 
cells  
(A) A scheme of the experiment protocol. The infection dose was 2)104 rLM-OVA. (B) 
The composition of the CD45.1+ input cell population prior to the transfer. (C) The 
numbers represent the total splenocytes and the indicated cells originating from the donor 
on day 7. p is > 0.05 if not indicated. (D and E) Frequencies of IFN-#-producing rLM-
OVA-specific CD8 (D) and CD4 (E) T cells after in vitro stimulation as in Fig 3.1. The 
FACS data shown were gated on donor populations. The values in representative FACS 
profiles are percentages of total donor splenocytes; the graphs on right represent 
percentages of total donor CD8 (D) or CD4 (E) T cells that produced IFN-#. The bars 
indicate the median value. (F) In vivo killing assay. Experiments were performed as 


















































Figure 3.4 T-CD4 cells inhibit development of memory CD8 effector cells 
(A) A scheme of the experiment protocol. Mice were infected with 2)103 and 5)105 
rLM-OVA for primary and secondary infection respectively, and then sacrificed three 
days after the second infection. (B) The composition of the CD45.1+ input cell 
populations prior to the transfer. (C) The numbers represent total splenocytes and the 
indicated cells originating from the donor. (D and E) Frequencies of IFN-#-producing 
rLM-OVA-specific CD8 (D) and CD4 (E) T cells (N=5). Experimental design and data 
analysis were performed as described in Figure 3 D and E. (F) Numbers represent viable 
bacteria isolated from liver homogenates. The bars indicate median values. The CFU 




































     












          
        
Figure 3.5 T-CD4 T cells suppress proliferation of CD8 T cells in a cell contact-
dependent manner 
(A) Antigen-specific T-CD4 T cells did not produce IL-4 after re-stimulation on day 7 of 
infection. Experimental design and data analysis were as described in Fig 3.1 B. (B) Tg 
and WT mice were infected intravenously with 5)104 rLM-OVA. Three days later, RNA 
was extracted from the spleen and quantitative RT-PCR was performed to measure 
cytokine gene expression. Relative expression of each cytokine was normalized to 
GAPDH. (C) Gr-1+ and/or F4/80+ subsets of Tg and WT splenocytes. Hosts were i.v. 
infected with 1)105 rLM-OVA and sacrificed on day 3 of the primary infection. (D) CD4 
depleted total splenocytes were labeled with CFSE and cultured in the presence of E- or 
T-CD4 T cells for three days. CFSE intensity (left) and IFN-# expression after short-term 
re-stimulation (right) are shown. (E) The CFSE profiles of CD8 T cells cultured with E- 
or T-CD4 supernatant for 4 days. (F) Representative profiles of Foxp3 expression in 
splenic CD4 T cells from BM chimeric mice (T-BMT: Tg!A!-/-; E-BMT: WT!WT). 
All experiments were done at least twice.  
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3.5 Discussion 
 The present study reported a novel suppressive role of T-CD4 T cells in adaptive 
immune responses against L. monocytogenes, evidenced by the low number of rLM-
OVA-specific CD8 T cells and compromised in vivo CTL killing potential. This is rather 
surprising since previously we have shown that T-CD4 T cells produce effector cytokines 
immediately after TCR stimulation (15, 21). This disparity is a good example of the 
differences between polyclonal stimulation and antigen-specific responses.  
 
The suppressed CTL response was evident in the memory phase, indicating T-
CD4 T cells also differ from E-CD4 T cells in their impact on CTL memory 
development. Several reports have demonstrated a critical role of E-CD4 T cells in 
establishing CTL-mediated immunological memory against intracellular pathogens such 
as L. monocytogenes (1, 2, 39, 40). Without E-CD4 T cells, hosts are capable of clearing 
pathogens efficiently during the primary response, but succumb after a high dose re-
encounter of the pathogen due to the defective function of memory CTLs. T-CD4 T cells, 
however, do not function analogously to E-CD4 T cells. As we demonstrated, 
immunological memory was compromised in the presence of T-CD4 T cells. The sub-
optimal CTL response in T-CD4 T cell hosts, especially during the memory response, 
cannot be attributed to a lower number of total or antigen-specific T-CD4 T cells than E-
CD4 T cells in the hosts. Instead, the suppressive effect appeared to be dominant and 
lasted throughout the entire period, because this suppression was also readily observed in 
Tg mice, which possess a good proportion of E-CD4 T cells in addition to T-CD4 T cells. 
Also intriguing is the observation that T-CD4 T cells could regulate CD8 T cell responses 
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by repressing expansion, rather than by altering the CD8 cells potential to produce IFN-#. 
Further studies will attempt to identify the cell surface molecules mediating suppression 
and to investigate the molecular mechanisms by which T-CD4 T cells repress CD8 T cell 
expansion in a cell contact-dependent manner. 
 
T-CD4 T cells share similarities with another innate T cell population known as 
iNKT cells (16, 19, 20). iNKT cells recognize glycolipid antigens presented by the 
nonpolymorphic MHC class I-like molecule CD1d (18). Similar to T-CD4 T cells, iNKT 
cells exhibit an effector cell phenotype, and respond quickly to TCR stimulation by 
producing effector cytokines. Moreover, iNKT cells have been reported to participate in 
immune regulation and in the protection against certain diseases (51-54). However, the 
functional characteristics of T-CD4 T cells seem to be quite different from iNKT cells in 
L. monocytogenes infection. First, the rapid iNKT cell response to infection can be 
readily observable by 4 days post infection (55). Consistent with this observation, 
cytokines such as IL-12 produced during an early stage of an immune response regulate 
iNKT cell activation in a non-antigen-specific way (17). Furthermore, the expression of 
the NK T cell marker NK1.1, which allows the recognition of "missing-self", seems also 
to play a role in iNKT cell regulation of L. monocytogenes infection, independent of TCR 
involvement (17, 56). By contrast, the presence of T-CD4 T cells conferred little 
detectable difference to the host environment regarding inflammatory cytokine levels at 
the early stage, indicating a lack of bystander response. Second, it has been reported that 
iNKT cells fail to expand after L. monocytogenes infection, and instead result in a 
prolonged loss in the spleen (57). T-CD4 T cells, on the other hand, seemed to expand 
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synchronously with E-CD4 T cells in an antigen-specific manner, but to a much milder 
extent. Finally, no suppressive role has been suggested thus far regarding iNKT cell 
function during L. monocytogenes infections as we have reported here for T-CD4 T cells.  
 
The suppressed proliferation of CD8 T cells co-cultured with T-CD4 T cells was 
not likely due to Treg populations, because T-CD4 T cells used in the assay did not 
contain more Treg than E-CD4 T cells based on Foxp3 staining and that Treg from T-
BMT hosts are functionally equivalent to those from E-BMT hosts (15). Furthermore, 
despite the suppressive function, T-CD4 T cells are distinct from Treg. Treg cells neither 
have pre-made IL-4 mRNAs nor release effector cytokines immediately after TCR 
stimulation. Instead, similarly to conventional CD4 T cells, Treg undergo several rounds 
of proliferation before functional maturation. They function to produce large amounts of 
suppressive cytokines including TGF-! and IL-10 instead of inflammatory cytokines 
such as IL-6 and IFN-# produced by T-CD4 T cells. Moreover, T-CD4 T cells seem to 
have less capacity to produce IL-10 and TGF-! than E-CD4 T cells (data not shown, by 
Jihoon Chang and Tim Voorhees).  
 
Previously, we have demonstrated that mice containing T-CD4 T cells are 
protected from airway inflammation (21). In addition, T-CD4 T cells also seem to 
suppress the onset of EAE (22). Based on these reports and our current study, it is likely 
that T-CD4 T cells act to down-regulate the host immune response in many other 
scenarios. A recent report showed the existence of T-CD4 T cells in humans (13). If 
human T-CD4 T cells bear a similar suppressive function to that shown here for murine 
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T-CD4 T cells, understanding the mechanisms underlying the phenomena described here 
can have clinical applications to infectious and autoimmune diseases in humans.  
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4.1 TCR signaling characteristics during T-CD4 T cell generation 
 TCR gene rearrangement during T cell development gives rise to millions of 
thymocytes with distinct TCRs to interact with self-MHC complexes. The TCR-ligand 
interaction is correlated with TCR signaling intensity, which in turn determines T cell 
fate – weak TCR signaling fails positive selection and strong TCR signaling leads to 
negative selection; only those thymocytes with moderate TCR ligation and signal 
transduction survive the screening process. With the notion that most of the thymocytes 
die from lack of surviving signals during positive selection, the TCR selection window is 
believed to be on the right half of the distribution curve (Fig 4.1 A, dash line). This model 
is also supported by the observation that weakened TCR signaling compromises E-CD4 T 
cell development (1-4) and that mildly elevated TCR signaling, enhances E-CD4 T cell 
generation (5). However, this model applies to E- but not T-CD4 T cells. TCR signaling 
modulation affected T-CD4 T cell selection oppositely to E-CD4 T cell selection –
reducing TCR signaling enhanced (Fig 2.1 B) and increasing TCR signaling impaired 
(Fig 2.2 B). T-CD4 T cell generation, suggesting that TCR signaling elicited by 
thymocyte-thymocyte (T-T) interaction is fundamentally different from that by epithelial 
cell-thymocyte (E-T) interaction. This is not surprising considering that thymocytes and 
TEC likely differ in many ways, including the intensity of MHC Class II expression, the 
 103 
pool of selecting self-peptides, the expression of different kinds of adhesion molecules 
and the dynamics of cell interactions. All these factors possibly influence the avidity 
and/or the longevity of TCR ligation, and thus in turn, the signaling quality.  
  
 Based on our data, we propose that the T-T interaction results in stronger TCR 
signaling than does the T-E interaction. According to this hypothesis, the distribution 
curve of TCR signal resulting from T-T interactions is to the right of that resulting from 
E-T interactions (Fig 4.1 A). This model predicts that decreasing TCR signaling strength 
favors T-CD4 T cell generation but compromises E-CD4 T cell generation (Fig 4.1 B), 
which is consistent with the observation in ITK deficiency. Similarly, increasing TCR 
signaling strength would produce an opposite effect that is consistent with our study with 
the RASA1-/- model (Fig 4.1 C). It should be mentioned that, in order to focus on the 
comparison between T- and E-CD4 TCR signaling characteristics in this model, we 
defined other factors such as the selection windows for T- and E-CD4 T cells to be 
identical. This is reasonable because thymocytes are instructed by the intrinsic signaling 
qualities but not by the interacting cell types per se. And even if the two windows do not 






     
 As shown in Fig 4.1, this model indicates that T- and E-CD4 T cells possess 
different TCR repertoires. And in fact, although FACS profiles did not show significant 
differences in TCR " and ! chain usage, there is accumulating evidence to support this 
hypothesis: AND T cells, having a transgenic TCR V#11V$3 pair that recognizes a 
0)8(3%!<,'3<743*(!<!0(0')/(-IEk complex in the periphery, can be efficiently selected 
by IAb or IEk expressed on TEC in the thymus (6). However, thymocytes bearing AND 
transgenic TCR fail to be selected by thymocyte-expressed MHC class II molecules to 
become T-CD4 T cells (7). Similarly, the DO11.10 and OT-II (8) CD4 TCRTg 
thymocytes that are efficiently selected by TEC cannot be selected by thymocytes ((7) 
and Fig A1.2). The reason for the differences between T- and E-selection of these 
transgenic TCRs is still elusive. It seems that AND or OT-II cell selection on thymocytes 
cannot be rescued by TCR signaling modulation, at least based on the study using the 
SAP, RASA1 or ITK deficient systems (Fig A1.1 and A1.2). While there is a possibility 
that the signal alternations in these models were not optimal for T-CD4 T cell selection, it 
is equally possible that these transgenic TCRs intrinsically belong to the E- but not to the 
T-CD4 TCR repertoire, the shaping of which can be influenced by factors such as self 
Fig 4.1 T cell selection model.  
Y-axes are the percentages of 
thymocytes. Shadows are selection 
windows. (A) (B) and (C) are TCR 
signaling distributions of T- and E-





peptides in addition to signaling properties. Evidence supporting this latter point of view 
arises from the generation of a transgenic TCR cloned from T-CD4 T cells. These TCRTg 
T cells express TCR V#2V$8 and are named T3 CD4 T cells (Appendix 1). They were 
poorly generated on TEC in E-BMT hosts when compared to polyclonal partner cells (T3 
+ WT !WT), but were efficiently generated with a highly increased percentage of T3 
CD4 SP population in T-BMT hosts (T3 + CIITATg ! A$-/-) (Fig A1.3). It is yet to be 
determined whether the T3 E-CD4 T cell generation can be rescued by modulating TCR 
signaling events. It is reasonable that, like AND and OT-II thymocytes in T-CD4 T cell 
selection, T3 E-CD4 T cells may fail to be rescued by TCR signaling modulation, which 
would suggest that T3 is specific for the T- but not the E-CD4 repertoire. It would not be 
surprising, however, if T3 E-CD4 T cell generation was rescued by signaling modulation, 
because T- and E-CD4 TCR repertoires may partially overlap (Fig 4.1 A). Whatever the 
case, the current data derived from AND, OT-II and T3 TCRTg models serve as strong 
indications of the differences between T- and E-CD4 TCR repertoires.  
4.2 T-CD4 T cell functional characteristics 
In our study with L. monocytogenes infection, the experiments using the adoptive 
transfer model clearly showed that T-CD4 T cells suppressed Listeria-specific CTL 
expansion (Fig 3.3 E) and decreased CTL killing capacity in vivo at a primary stage (Fig 
3.3 G). Our current data suggested that the suppressive function of T-CD4 T cells was 
performed by a population other than Foxp3-expressing Treg cells, in that T-CD4 T cells 
do not contain more Treg than E-CD4 T cells (Fig 3.5 E), and that Treg from T-BMTs do 
not suppress cell proliferation with stronger potency than Treg from E-BMT hosts (7). 
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Nevertheless, more studies are needed to establish the mechanisms underlying the 
suppressive nature of T-CD4 T cells.  
 
Similar to Tregs, T-CD4 T cells suppress cell proliferation through cell contact-
dependent pathways in vitro. Treg suppression depends on accessory molecules such as 
CTLA-4 (CD152) and lymphocyte-activation gene 3 (LAG3) interacting with their 
ligands on APCs (9). It remains to be determines whether these two molecules play a role 
in T-CD4 T cell suppressive function. Another possible mechanism of T-CD4 T cell 
suppression may be granzyme-mediated cytolysis, since our microarray analysis showed 
that T-CD4 T cells had higher mRNA levels of multiple granzymes than E-CD4 T cells. 
Studies have shown that granzyme-mediated cytolysis is employed by Tregs to kill the 
APCs and thereby limits antigen-presentation to other T cells for activation and 
proliferation (10-12). We further need to determine whether T-CD4 T cells also employ 
this mechanism to kill the APCs or other T cells they are interacting with. Regarding 
cytokine regulation, unlike Tregs that produce the suppressive cytokines IL-10 and TGF-
$, which are important for immune regulation in mouse models such as colitis (13) and 
allogeneic skin graft rejection (14), T-CD4 T cells do not produce higher amounts of IL-
10 or TGF-$ than E-CD4 T cells in vitro, and the status of IL-10 and TGF-$ production 
by T-CD4 T cells in vivo is unknown. 
 
Participation of CD8 T cells and iNKT cells in an immune response can be 
observed much earlier than that of conventional T cells. T-CD4 T cells also distinguish 
themselves from E-CD4 T cells by the immediate effector cytokine production after anti-
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CD3 stimulation in vitro and in vivo (15). Therefore, it seems reasonable to expect that T-
CD4 T cells will react with effector T cells shortly after infections in vivo. During 
L.monocytogenes infection, however, the function and influence of T-CD4 T cells were 
mainly in adaptive immune responses rather than at earlier stages, as shown by the 
measurement of cytokine expression (Fig 3.5 A) and by the innate cell profile (Fig 3.5 
G). One explanation for the disparity between polyclonal and antigen-specific systems as 
well as for that between T-CD4 and other innate-like T cell populations may lie in the 
nature of their TCR ligands. Most of innate-like T cells such as iNKT and innate CD8 T 
cells have either a conserved TCR repertoire or less specific TCR recognition than that of 
conventional T cells. For example, iNKT cells recognize glycolipids presented by 
nonpolymorphic CD1d, and the whole iNKT population can be detected by #Galer-CD1d 
complexes (16). H2-M3-restricted CD8 T cells have been shown to recognize a broad 
spectrum of N-terminally formylated peptides by a single TCR (17). Therefore, the 
relatively large pools of these CD8-T responding cells facilitate their expansion-
independent detection, and thus their activity can be readily assessed early on. T-CD4 T 
cells, on the other hand, use peptide-MHC class II complexes as TCR ligands, which are 
much more specific than MHC class Ib complexes and thus tend to select TCRs of higher 
specificity. The frequency of T-CD4 T cells specific for a certain pathogen in a host is 
likely comparable to that of E-CD4 T cells. It would be extremely difficult to detect these 
few cells even if they were producing cytokines immediately after stimulation in vivo. 
And their low cell numbers also made them unlikely to exert a dramatic influence on the 
whole inflammatory environment at early stages. However, if antigen-specific T-CD4 T 
cells indeed produce cytokines while they are interacting with the APCs, these cytokines 
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may affect APC function and in turn the programming of the later responses. The 
investigation of this aspect remains to be done.  
 
An alternative explanation for the dual functional features of immediate cytokine 
production and proliferation suppression during infection is T-CD4 T cell heterogeneity. 
It has been noted that T-CD4 T cells are comprised of different subsets. T-CD4 T cells 
with an IL-4 mRNA-GFP reporter (18) express GFP in approximately 50% of the CD4SP 
cells in the thymus and in 30-40% of the splenocytes (H. Sofi et al., paper submitted). In 
addition, in the thymus, GFP+ T-CD4 T cells express higher levels of Ly108 and CD44 
than GFP- T-CD4 T cells. Furthermore, the transcription factor PLZF is also expressed 
heterogeneously in T-CD4 T populations. And interestingly, PLZF is mostly expressed in 
the IL-4 mRNA-expressing T-CD4 SP thymocytes, whereas non-IL-4 mRNA-expressing 
cells are mostly PLZF-. Therefore, it seems that T-CD4 T cells are comprised of sub-
populations of IL-4+PLZF+, IL-4+PLZF- and IL-4-PLZF- cells. These subsets might 
possess different functional characteristics. For example, IL-4 mRNA-expressing cells 
might be the immediate IL-4 producers. It is also not known whether the suppressive T-
CD4 T cells belong to certain subsets. 
 
It is also known that T-CD4 T cells continue producing IL-4 under Th1-skewing 
conditions in vitro. But on day 7 of L.monocytogenes infection, no Listeria-specific IL-4-
producing CD4 T cells were detected in T-CD4 T cell hosts. This is a good example 
showing that polyclonal stimulations in vitro do not always mirror the antigen-specific 
responses under physiological conditions. It is likely that there are Listeria-specific T-
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CD4 T cells with IL-4 producing potential upon infection, but they may not expand well 
or may lose the IL-4 producing capacity during L.monocytogenes infection.  
 
The immune deficiency caused by T-CD4 T cells was preserved in immune 
memory (Fig 3.4 E). However, it is not yet clear whether the deficiency at the memory 
stage is due to dominant suppression by memory T-CD4 T cells or is due to the defective 
development of CTL memory as a consequence of deficient primary adaptive immune 
response. To arrive at a conclusive answer, a model of secondary adoptive transfer is 
needed to separate the role of T-CD4 T cells in establishing CTL immune memory from 
their function in memory immune responses. Nevertheless, current data clearly showed 
that, under physiological conditions, the presence of T-CD4 T cells resulted in deficient 
CTL responses at both primary and memory phases. 
4.3 Acquisition of functional characteristics during T-CD4 T cell development  
The functional characteristics of T-CD4 T cells are shaped in the thymus, but the 
mechanism is still a subject for discussion and speculation.  
 
TCR signaling events during and after positive selection might be critical for 
shaping T-CD4 T cell function. TCR signals for positive selection at the DP stage have 
been known to be important for lineage decisions. Upon positive selection, thymocytes 
differentiate into CD4 or CD8 T cells. CD4 T cell differentiation requires stronger TCR 
signals than CD8 T cell differentiation does, but purely weakening TCR signaling does 
not necessarily affect lineage decision as shown in an ITK-/- mouse model (3). Moreover, 
Treg development is regulated by TCR signals differently from effector E-CD4 T cells, 
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as reflected by the inherited differences of the TCR characteristics of the two. Treg TCRs 
display higher ligation affinity than effector E-CD4 TCRs based on the studies with 
TCRTg models, and Tregs have been proposed to recognize self-antigens in the periphery 
(19). In addition, iNKT cell TCR-CD1d interaction has been suggested to be of higher 
affinity and longer half life than E-CD4 T cell TCR-MHC class II interaction as 
measured using hybridoma systems (20). Thus, T-CD4 lineage decisions might also be 
made through T-T interaction during positive selection.  
 
Beyond positive selection, the functional maturation of T-CD4 T cells might 
employ a secondary step that probably involves a unique type of TCR stimulation. This 
stimulation leads to slow T-CD4 T cell proliferation indicated by a CD71+ FSChi 
phenotype (data not shown), the up-regulation of CD44 and the transcription of IL-4 
mRNAs, instead of inducing apoptosis as in negative selection. There are at least two 
potential reasons for T-CD4 T cells escaping apoptosis by TCR stimulation at this stage. 
First, T-CD4 T cells might be better at resisting apoptosis than E-CD4 T cells because of 
some special programming during the T-T interaction earlier. Second, according to our 
hypothesis that T-T interactions produce higher TCR signaling strength for a given TCR 
than does the E-T interaction, thymocytes with too weak a TCR-ligand interaction for E-
CD4 positive selection by TEC might survive T-CD4 positive selection by thymocytes. 
These T-thymocytes respond to a lesser extent than E-thymocytes to the same TCR 
ligation in the medulla (Fig 4.1 A). It is possible that, because of the weak TCR signals 
produced, some of these T-thymocytes are sub-optimally stimulated by recognizing self-
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peptides instead of being depleted through negative selection. Consequently, they display 
activated phenotype. 
 
In addition to TCR signaling, co-stimulatory pathways might also contribute to 
shaping the T-CD4 T cell functional characteristics. CD28 and SLAM-SAP pathways 
have been suggested to be critical for Treg (21) and iNKT development (22), 
respectively, and both pathways are important for the innate-like functional phenotype of 
a CD8 T cell population (22, 23). As for T-CD4 T cells, SLAM family receptors signal at 
the DP stage and are important for optimal selection. This pathway partially affects T-
CD4 T cell phenotype, as demonstrated by SAP deficiency studies that showed a two-
fold decrease in the IL-4-producing population under Th1-skewing conditions (24). Since 
SAP deficiency does not completely abolish IL-4 production by T-CD4 T cells, other 
pathways probably participate in the process as well. In the medulla, the CD28 pathway 
is a good candidate for driving the T-CD4 T cell functional phenotype, since the role of 
CD28 signals in Treg and innate CD8 T cell development has been established.  
 
The differentiation of different T cell lineages is quite often marked by up-
regulation of specific transcription factors. Foxp3 is a critical transcriptional factor for 
Treg; its deficiency abolishes Treg generation and leads to autoimmune disorders. PLZF 
has recently been identified as a crucial transcriptional factor for iNKT cell generation 
and function; PLZF deficient iNKT cells exhibit a naive phenotype, defective expansion 
in the thymus and compromised cytokine production after activation (25). Similarly, 
PLZF is also expressed in T-CD4 T cells (Fig 2.5 C), and likely plays a role in shaping T-
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CD4 phenotype. However, unlike iNKT cells, only one third of T-CD4 SP thymocytes 
express PLZF, an indication that T-CD4 T cells contain different subsets. Moreover, 
over-expression of PLZF in E-CD4 T cells does not increase IL-4 production in these 
cells (26), suggesting that other factors in addition to PLZF are required for expression of 
T-CD4 T cell functional characteristics. PLZF is induced at the SP stage after positive 
selection, but the exact up-stream signaling events that induce or regulate its expression 
are poorly defined. At this point, PLZF target genes are not well identified either. 
Addressing these two questions would help reveal the molecular mechanisms that relate 
T-CD4 T cell function to their development. 
4.4 The implications of this study  
 This study focused on T-CD4 T cells and provided insights into their generation 
and function in the hopes that some of our findings will have diagnostic implications and 
potentially influence clinical treatments in disease. Our studies in mice indeed have 
human implications:  Human thymocytes express MHC class II molecules (27-29), and 
CD4 T cells generated through T-T interaction have been found in human fetus tissues 
(30). Moreover, these human T-CD4 T cells expressed PLZF and produced elevated IL-4 
cytokine similar to mouse T-CD4 T cells. The identification of these cells opened a new 
avenue of T cell research along with giving rise to many immediate questions to be 
addressed further, such as their generation in adults and their persistence and 
physiological functions in the periphery. It is technically a challenge to address these 
questions in humans directly. Therefore, mouse models that have been and will be 
constructed can provide fertile testing grounds to facilitate the design and conduct of 
future human studies.  
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 The results of our study of T-CD4 T cells have implications for both healthy 
humans and human disease. In patients receiving bone marrow transplant treatment, for 
example, both T- and E-CD4 T cells can exist. Moreover, in BLS patients who receive 
bone marrow transplants, all of the restored CD4 T cells (31, 32) are selected by BM-
derived cells, and therefore resemble T-CD4 T cells. Whereas E-CD4 T cells are host 
MHC-restricted, T-CD4 T cells are donor MHC-restricted, which should be taken into 
consideration for host-graft tolerance. More importantly, the immune responses of these 
patients cannot be predicted solely with conventional concepts of the immune system, 
and the functional differences between T- and E-CD4 T cells need be considered. If 
human T-CD4 T cells possess the same suppressive function as mouse T-CD4 T cells do, 
they could be beneficial in reducing autoimmune reactions. In situations where the 
suppressive immune function is desired, T-CD4 T cell adoptive transfer is a feasible 
strategy, considering human T-CD4 T cells have been successfully generated in vitro (33) 
and in vivo (34). Importantly, these T-CD4 T cells display functional maturity in vitro 
and in vivo, shown by cytokine production and the responsiveness to vaccination and 
viral infection (34, 35). However, the suppressive function of T-CD4 T cells might be 
disastrous for immune responses against foreign pathogens. Strategies such as drug 
administration to boost T cell activities should be employed to cope with the potentially 
blunted immunity, and further identification of T-CD4 T cell specific markers would be 
very helpful for cell-specific depletion.  
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The studies presented in this thesis have provided a novel perspective on the 
immune system and CD4 T cell biology, which can help foster better design of the 
strategies needed to treat certain diseases. In addition, it also raised new questions for 
future research so as to better understand the mechanisms underlying pathologies that 
relate to the immune system. 
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Appendix 1:  Development of thymocytes expressing TCRs with a single specificity 
 
 As an attempt to further characterize TCR signaling characteristics in T- vs E-
CD4 development, we modulated and evaluated the selection efficiency of a homogenous 
T cell population bearing the transgenic TCR AND. AND TCR transgenic (TCRTg) CD4 
T cells (1) express V#11 and V$3 and can be efficiently selected by MHC class II 
expressed on TEC (2, and Fig A1.1 A). However, they failed to develop into T-CD4 T 
cells (Fig A1.1 A). Moreover, this failure of thymocyte-mediated selection was not 
rescued when the TCR signaling quality was altered by eliminating ITK (Fig A1.1 B), 
RASA1 (Fig A1.1 C), or SAP (Fig A1.1 D). Similarly, OT-II (2) (V#2+V$5+) TCRTg 
thymocytes were efficiently selected by TEC but were poorly selected by thymocytes 
(Fig A1.2 A and C), and their selection was not improved by ITK deficiency (Fig A1.2 B 
and C).  
  
 The results above raised the possibility that T- and E-CD4 T cells possess 
different TCR repertoires, and that the developmental failure of AND and OT-II T-CD4 
T cells is because these two transgenic TCRs were cloned from E-CD4 T cells that are 
not shared by T-CD4 T cells. If so, thymocytes bearing TCRs expressed in T-CD4 T cells 
would be selected better by thymocytes than by TEC. To test the hypothesis, we 
generated a new line of TCR transgenic mice named T3 (T-CD4 TCR Transgenic). To 
obtain T3, we first constructed T-BMT chimeras by transferring TCR V$8Tg BM cells 
with CIITATg BM cells to A$-/- hosts. Eight weeks later, Va2+V$8+ splenic CD4 T cells 
originated from TCR V$8Tg BM were sorted and Va2 genes from these T-CD4 T cells 
were sequenced. The most frequently expressed V"2 gene and the V$8 gene was cloned 
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to an expression vector and the standard protocol generating transgenic mice was 
followed to make T3 mice.  
 The selection preference of T3 CD4 T cells was tested using the BM chimeric 
strategy. CD4 SP thymocytes originated from T3 BM expressed the transgenic TCR V"2 
and V!8, and importantly, T3 CD4 T cell development was better by thymocytes than by 


























Figure A1.1 Poor selection of AND CD4 T cells by thymocytes  
BM cells (CD45.2+) from AND (A), AND/ITK-/- (B), AND/RASA1-/- (C), and 
AND/SAP-/y mice (D) were co-transferred with WT BM (CD45.1+CD45.2+) into B6.SJL 
hosts (CD45.1+) to generate E-CD4 T cells (left), and with CIITATg BM 
(CD45.1+CD45.2+) into A$-/- hosts (CD45.1+) to generate T-CD4 T cells (right). The 
transfer ratio of AND TCR-expressing cells to partner cells was 10:1 in all groups. Mice 
were sacrificed 5-6 weeks after the BM transplantation. Total thymocytes were used to 
analyze thymocyte subsets (upper panels of the FACS profile in each Figure). The 
numbers in the dot plots indicate the percentages of gated cells derived from each BM 
type using the CD45 allele. The lower panels are TCR expression of CD4 SP thymcoytes 
of the indicated donor cells. The numbers are percentages of the cells within each CD4 
SP population. The bar graphs shown are selection efficiencies expressed as mean±SE 
(right) were calculated as in Fig 2.1. The y axis’s are in log 2 scale, and the numbers are 






Figure A1.2 Inefficient development of OT-II TCRTg CD4 T cells by thymocytes.  
OT-II (A) and OT-II/ITK-/- (B) BM (CD45.2+) were co-transferred with WT BM 
(CD45.1+CD45.2+) into B6.SJL hosts (CD45.1+) to generate E-CD4 T cells (left), and 
were co-transferred with CIITATg BM (CD45.1+CD45.2+) into A$-/- hosts (CD45.1+) to 
generate T-CD4 T cells (right). The transfer ratio of OT-II TCR-expressing cells to 
partner cells was 10:1 in all groups. Mice were sacrificed 5 weeks after the BM 
transplantation, and the thymocytes were analyzed as in Fig A1. The selection 
efficiencies shown in bar graphs were expressed as mean±SE (right) as in Fig 2.1. The y 
axis’s are in log 2 scale, and the numbers are the logarithms of 2. (A: N=2, 3; B: N=4, 2.) 





Figure A1.3 Better selection of T3 CD4 T cells by thymocytes than TEC 
T3 BM (CD45.2+) were co-transferred with WT BM (CD45.1+CD45.2+) into B6.SJL 
hosts (CD45.1+) to generate E-CD4 T cells (left), and were co-transferred with CIITATg 
BM (CD45.1+CD45.2+) into A$-/- hosts (CD45.1+) to generate T-CD4 T cells (right). The 
transfer ratio of T3 cells to partner cells was 3:1 in both groups. Mice were sacrificed 4 
weeks after the BM transplantation. TCR expression of CD4 SP was shown in the bottom 
panels. The data are representative of multiple experiments. 
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